BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, Boztug K, Pfeifer D, Kreipe H, Pfister ED, Baumann U, Puchalka J, Bohne J, Egritas O, Dalgic B, Kolho KL, Sauerbrey A, Buderus S, Güngör T, Enninger A, Koda YK, Guariso G, Weiss B, Corbacioglu S, Socha P, Uslu N, Metin A, Wahbeh GT, Husain K, Ramadan D, Al-Herz W, Grimbacher B, Sauer M, Sykora KW, Koletzko S, Klein C. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 2012;143:347-55. [PMID: 22549091 DOI: 10.1053/j.gastro.2012.04.045] [Cited by in Crossref: 327] [Cited by in F6Publishing: 335] [Article Influence: 29.7] [Reference Citation Analysis]
Number Citing Articles
1 Saez A, Herrero-Fernandez B, Gomez-Bris R, Sánchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of Inflammatory Bowel Disease: Innate Immune System. Int J Mol Sci 2023;24. [PMID: 36675038 DOI: 10.3390/ijms24021526] [Reference Citation Analysis]
2 Lee W, Chen C, Chen S, Lai W, Jaing T, Ou L, Liang C, Kang C, Huang J. Clinical features and genetic analysis of Taiwanese primary immunodeficiency patients with prolonged diarrhoea and monogenetic inflammatory bowel disease.. [DOI: 10.21203/rs.3.rs-2421155/v1] [Reference Citation Analysis]
3 Tang Z, Sun S, Ji M, Shi P, Wang Y, Huang Z, Huang Y. Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency.. [DOI: 10.21203/rs.3.rs-2410613/v1] [Reference Citation Analysis]
4 Koletzko S, Weise U. CED bei Kindern und Jugendlichen. Pflege bei chronisch-entzündlichen Darmerkrankungen 2023. [DOI: 10.1007/978-3-662-64938-1_25] [Reference Citation Analysis]
5 Illig D, Kotlarz D. Dysregulated inflammasome activity in intestinal inflammation - Insights from patients with very early onset IBD. Front Immunol 2022;13:1027289. [PMID: 36524121 DOI: 10.3389/fimmu.2022.1027289] [Reference Citation Analysis]
6 Aschenbrenner D, Ye Z, Zhou Y, Hu W, Brooks I, Williams I, Capitani M, Gartner L, Kotlarz D, Snapper SB, Klein C, Muise AM, Marsden BD, Huang Y, Uhlig HH. Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications. J Clin Immunol 2022. [DOI: 10.1007/s10875-022-01366-7] [Reference Citation Analysis]
7 Korol CB, Belkaya S, Alsohime F, Lorenzo L, Boisson-dupuis S, Brancale J, Neehus A, Vilarinho S, Zobaida A, Halwani R, Al-muhsen S, Casanova J, Jouanguy E. Fulminant Viral Hepatitis in Two Siblings with Inherited IL-10RB Deficiency. J Clin Immunol 2022. [DOI: 10.1007/s10875-022-01376-5] [Reference Citation Analysis]
8 Meena S, Varla H, Swaminathan VV, Chandar R, Jayakumar I, Ramakrishnan B, Uppuluri R, Raj R. Hematopoietic stem cell Transplantation in Children with very Early Onset Inflammatory Bowel Disease Secondary to Monogenic Disorders of immune-dysregulation. Indian J Hematol Blood Transfus 2022. [DOI: 10.1007/s12288-022-01586-2] [Reference Citation Analysis]
9 Wang D, Jin H, Sheng J, Cheng L, Lin Q, Lazerev M, Jin P, Li X. A high salt diet protects interleukin 10-deficient mice against chronic colitis by improving the mucosal barrier function. Mol Immunol 2022;150:39-46. [PMID: 35944464 DOI: 10.1016/j.molimm.2022.07.010] [Reference Citation Analysis]
10 Sharifinejad N, Zaki-Dizaji M, Sepahvandi R, Fayyaz F, Dos Santos Vilela MM, ElGhazali G, Abolhassani H, Ochs HD, Azizi G. The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review. Clin Exp Immunol 2022;208:281-91. [PMID: 35481870 DOI: 10.1093/cei/uxac040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ye Z, Qian L, Hu W, Miao S, Wang Y, Lu J, Zhou Y, Lu X, Zhang Y, Zheng C, Sun H, Tang W, Tang Z, Sun S, Dong K, Qian X, Zhai X, Huang Y. Clinical outcome of infantile-onset inflammatory bowel disease in 102 patients with interleukin-10 signalling deficiency. Aliment Pharmacol Ther 2022;55:1414-22. [PMID: 35187668 DOI: 10.1111/apt.16837] [Reference Citation Analysis]
12 Achini‐gutzwiller FR, Snowden JA, Corbacioglu S, Greco R, Greco R, Alexander T, Snowden J, Badoglio M, Labopin M, Abinun M, Apte S, Arnold R, Domenech A, Brierley C, Burman J, Castilla‐llorente C, Cooper N, Daghia G, Daikeler T, Papa N, Vries‐bouwstra J, Farge D, Finke J, Hagglund H, Hawkey C, Henes J, Hiepe F, Jessop H, Kiely D, Kazmi M, Kirgizov K, Kramer E, Mancardi G, Marjanovic Z, Martin R, Martin T, Ma D, Moore J, Miller P, Muraro P, Oliveira M, Polushin A, Onida F, Simoes B, Puyade M, Resnick I, Ricart E, Rovira M, Saccardi R, Saif M, Sakellari I, Sharrack B, Snarski E, Scherer HU, Sossa C, Withers B, Wulffraat N, Zaccara E, Amrolia P, Ansari M, Balduzzi A, Corbacioglu S, Dalassier A, Dalle J, Diaz CH, Feuchtinger T, Locatelli F, Lucchini G, Galimard J, Vincent MG, Handgretinger R, Kleinschmidt K, Lawitschka A, Martinez AP, Peters C, Rocha V, Ruggeri A, Sedlacek P, Svec P, Toporski J, Yesilipek A; The EBMT Autoimmune Diseases (ADWP) and Paediatric Diseases (PDWP) Working Parties. Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation. Br J Haematol. [DOI: 10.1111/bjh.18176] [Reference Citation Analysis]
13 Levine AE, Zheng HB, Suskind DL. Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations. Pediatr Drugs. [DOI: 10.1007/s40272-022-00503-4] [Reference Citation Analysis]
14 Flinn AM, Gennery AR. Primary immune regulatory disorders: Undiagnosed needles in the haystack? Orphanet J Rare Dis 2022;17:99. [PMID: 35241125 DOI: 10.1186/s13023-022-02249-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li Q, Zhang H, Dai S. New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease. Front Pediatr 2022;10:714054. [DOI: 10.3389/fped.2022.714054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sasahara Y, Uchida T, Suzuki T, Abukawa D. Primary Immunodeficiencies Associated With Early-Onset Inflammatory Bowel Disease in Southeast and East Asia. Front Immunol 2021;12:786538. [PMID: 35095863 DOI: 10.3389/fimmu.2021.786538] [Reference Citation Analysis]
17 Ranjbar R, Ghasemian M, Maniati M, Hossein Khatami S, Jamali N, Taheri-anganeh M. Gastrointestinal disorder biomarkers. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.02.013] [Reference Citation Analysis]
18 El Sayed S, Patik I, Redhu NS, Glickman JN, Karagiannis K, El Naenaeey ESY, Elmowalid GA, Abd El Wahab AM, Snapper SB, Horwitz BH. CCR2 promotes monocyte recruitment and intestinal inflammation in mice lacking the interleukin-10 receptor. Sci Rep 2022;12:452. [PMID: 35013585 DOI: 10.1038/s41598-021-04098-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wilkins BJ, Kelsen JR, Conrad MA. A Pattern-based Pathology Approach to Very Early-onset Inflammatory Bowel Disease: Thinking Beyond Crohn Disease and Ulcerative Colitis. Adv Anat Pathol 2022;29:62-70. [PMID: 34813528 DOI: 10.1097/PAP.0000000000000327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Tai SL, Mortha A. Macrophage control of Crohn's disease. International Review of Cell and Molecular Biology 2022. [DOI: 10.1016/bs.ircmb.2022.01.003] [Reference Citation Analysis]
21 Mcfarlane A, Fyfe PK, Moraga I. Cytokine Receptors. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00112-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Aloi M, Cucchiara S. Crohn’s Disease. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2022. [DOI: 10.1007/978-3-030-80068-0_28] [Reference Citation Analysis]
23 El-sahhar S, Varga-weisz P. The gut microbiome in health and disease: Inflammatory bowel diseases. Advances in Ecological Research 2022. [DOI: 10.1016/bs.aecr.2022.09.005] [Reference Citation Analysis]
24 Brazil JC, Parkos CA. Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation. Mucosal Immunol 2021. [PMID: 34782709 DOI: 10.1038/s41385-021-00466-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Sandy NS, Marega LF, Bechara GD, Riccetto AGL, Bonfim C, Vilela MMDS, Ribeiro AF, Servidoni MF, Lomazi EA. Elevated IgA and IL-10 levels in very-early-onset inflammatory bowel disease secondary to IL-10 receptor deficiency. Rev Paul Pediatr 2021;40:e2020434. [PMID: 34730757 DOI: 10.1590/1984-0462/2022/40/2020434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Kidess E, Kleerebezem M, Brugman S. Colonizing Microbes, IL-10 and IL-22: Keeping the Peace at the Mucosal Surface. Front Microbiol 2021;12:729053. [PMID: 34603258 DOI: 10.3389/fmicb.2021.729053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Ackermann M, Mucci A, McCabe A, Frei S, Wright K, Snapper SB, Lachmann N, Williams DA, Brendel C. Restored Macrophage Function Ameliorates Disease Pathophysiology in a Mouse Model for IL10 Receptor-deficient Very Early Onset Inflammatory Bowel Disease. J Crohns Colitis 2021;15:1588-95. [PMID: 33596307 DOI: 10.1093/ecco-jcc/jjab031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
28 Jacobse J, Li J, Rings EHHM, Samsom JN, Goettel JA. Intestinal Regulatory T Cells as Specialized Tissue-Restricted Immune Cells in Intestinal Immune Homeostasis and Disease. Front Immunol 2021;12:716499. [PMID: 34421921 DOI: 10.3389/fimmu.2021.716499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
29 Saha P, Golonka RM, Abokor AA, Yeoh BS, Vijay-Kumar M. IL-10 Receptor Neutralization-Induced Colitis in Mice: A Comprehensive Guide. Curr Protoc 2021;1:e227. [PMID: 34399038 DOI: 10.1002/cpz1.227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Nguyen HD, Aljamaei HM, Stadnyk AW. The Production and Function of Endogenous Interleukin-10 in Intestinal Epithelial Cells and Gut Homeostasis. Cell Mol Gastroenterol Hepatol 2021;12:1343-52. [PMID: 34271223 DOI: 10.1016/j.jcmgh.2021.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
31 Mas-Orea X, Sebert M, Benamar M, Petitfils C, Blanpied C, Saoudi A, Deraison C, Barreau F, Cenac N, Dietrich G. Peripheral Opioid Receptor Blockade Enhances Epithelial Damage in Piroxicam-Accelerated Colitis in IL-10-Deficient Mice. Int J Mol Sci 2021;22:7387. [PMID: 34299013 DOI: 10.3390/ijms22147387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Rubalcava NS, Gadepalli SK. Inflammatory Bowel Disease in Children and Adolescents. Adv Pediatr 2021;68:121-42. [PMID: 34243849 DOI: 10.1016/j.yapd.2021.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
33 Hung HH, Lee HC, Yeung CY, Wang NL, Tang TY, Winter HS, Kelsen JR, Jiang CB. Importance of early detection of infantile inflammatory bowel disease with defective IL-10 pathway: A case report. Medicine (Baltimore) 2021;100:e25868. [PMID: 34032699 DOI: 10.1097/MD.0000000000025868] [Reference Citation Analysis]
34 Dong F, Xiao F, Ge T, Li X, Xu W, Wu S, Zhang T, Wang Y. Case Report: A Novel Compound Heterozygous Mutation in IL-10RA in a Chinese Child With Very Early-Onset Inflammatory Bowel Disease. Front Pediatr 2021;9:678390. [PMID: 34113591 DOI: 10.3389/fped.2021.678390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Ashton JJ, Mossotto E, Stafford IS, Haggarty R, Coelho TAF, Batra A, Afzal NA, Mort M, Bunyan D, Beattie RM, Ennis S. Genetic Sequencing of Pediatric Patients Identifies Mutations in Monogenic Inflammatory Bowel Disease Genes that Translate to Distinct Clinical Phenotypes. Clin Transl Gastroenterol 2020;11:e00129. [PMID: 32463623 DOI: 10.14309/ctg.0000000000000129] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
36 Razzaghian HR, Sharafian Z, Sharma AA, Boyce GK, Lee K, Da Silva R, Orban PC, Sekaly RP, Ross CJ, Lavoie PM. Neonatal T Helper 17 Responses Are Skewed Towards an Immunoregulatory Interleukin-22 Phenotype. Front Immunol 2021;12:655027. [PMID: 34012439 DOI: 10.3389/fimmu.2021.655027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Hemmati AA, Sistani Karampour N, Dahanzadeh S, Sharif Makhmalzadeh B, Rezaie A, Ghafourian M. The Protective Effects of Nebulized Nano-Curcumin Against Bleomycin-Induced Pulmonary Fibrosis in Rats. Jundishapur J Nat Pharm Prod 2021;16. [DOI: 10.5812/jjnpp.106961] [Reference Citation Analysis]
38 Morita M, Takeuchi I, Kato M, Migita O, Jimbo K, Shimizu H, Yoshimura S, Tomizawa D, Shimizu T, Hata K, Ishiguro A, Arai K. Intestinal outcome of bone marrow transplantation for monogenic inflammatory bowel disease. Pediatr Int 2021. [PMID: 33884705 DOI: 10.1111/ped.14750] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Tang Z, Zhang P, Ji M, Yin C, Zhao R, Huang Z, Huang Y. Characterization of novel and large fragment deletions in exon 1 of the IL10RA gene in Chinese children with very early onset inflammatory bowel diseases. BMC Gastroenterol 2021;21:167. [PMID: 33849446 DOI: 10.1186/s12876-021-01756-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Marafini I, Monteleone G. Precision Medicine in Inflammatory Bowel Diseases. Front Pharmacol 2021;12:653924. [PMID: 33927628 DOI: 10.3389/fphar.2021.653924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
41 Troncone E, Marafini I, Stolfi C, Monteleone G. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer. Int J Mol Sci 2021;22:3922. [PMID: 33920230 DOI: 10.3390/ijms22083922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Onfroy-Roy L, Hamel D, Malaquin L, Ferrand A. Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation? Cancers (Basel) 2021;13:1749. [PMID: 33916891 DOI: 10.3390/cancers13081749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 An SY, Petrescu AD, DeMorrow S. Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis. Front Pharmacol 2021;12:645703. [PMID: 33841164 DOI: 10.3389/fphar.2021.645703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
44 Hoffmann D, Sens J, Brennig S, Brand D, Philipp F, Vollmer Barbosa P, Kuehle J, Steinemann D, Lenz D, Buchegger T, Morgan M, Falk CS, Klein C, Lachmann N, Schambach A. Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages. J Pers Med 2021;11:221. [PMID: 33804706 DOI: 10.3390/jpm11030221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Krawiec P, Pawłowska-Kamieniak A, Pac-Kożuchowska E. Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson. J Inflamm (Lond) 2021;18:13. [PMID: 33691712 DOI: 10.1186/s12950-021-00279-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
46 Horowitz JE, Warner N, Staples J, Crowley E, Gosalia N, Murchie R, Van Hout C, Fiedler K, Welch G, King AK, Reid JG, Overton JD, Baras A, Shuldiner AR, Griffiths A, Gottesman O, Muise AM, Gonzaga-Jauregui C. Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn's Disease. Sci Rep 2021;11:5595. [PMID: 33692434 DOI: 10.1038/s41598-021-84938-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
47 Uhlig HH, Charbit-Henrion F, Kotlarz D, Shouval DS, Schwerd T, Strisciuglio C, de Ridder L, van Limbergen J, Macchi M, Snapper SB, Ruemmele FM, Wilson DC, Travis SPL, Griffiths AM, Turner D, Klein C, Muise AM, Russell RK; Paediatric IBD Porto group of ESPGHAN. Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2021;72:456-73. [PMID: 33346580 DOI: 10.1097/MPG.0000000000003017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 21.0] [Reference Citation Analysis]
48 Nedelkopoulou N, Taparkou A, Agakidis C, Mavroudi A, Xinias I, Farmaki E. IL-10 receptor expression on lymphocytes and monocytes in children with food allergy. Pediatr Allergy Immunol 2021;32:1108-11. [PMID: 33595140 DOI: 10.1111/pai.13475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Béziat V, Tavernier SJ, Chen YH, Ma CS, Materna M, Laurence A, Staal J, Aschenbrenner D, Roels L, Worley L, Claes K, Gartner L, Kohn LA, De Bruyne M, Schmitz-Abe K, Charbonnier LM, Keles S, Nammour J, Vladikine N, Maglorius Renkilaraj MRL, Seeleuthner Y, Migaud M, Rosain J, Jeljeli M, Boisson B, Van Braeckel E, Rosenfeld JA, Dai H, Burrage LC, Murdock DR, Lambrecht BN, Avettand-Fenoel V, Vogel TP, Esther CR, Haskologlu S, Dogu F, Ciznar P, Boutboul D, Ouachée-Chardin M, Amourette J, Lebras MN, Gauvain C, Tcherakian C, Ikinciogullari A, Beyaert R, Abel L, Milner JD, Grimbacher B, Couderc LJ, Butte MJ, Freeman AF, Catherinot É, Fieschi C, Chatila TA, Tangye SG, Uhlig HH, Haerynck F, Casanova JL, Puel A; Undiagnosed Diseases Network. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med 2020;217:e20191804. [PMID: 32207811 DOI: 10.1084/jem.20191804] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
50 Ye Z, Hu W, Wu B, Zhang Y, Lei C, Williams I, Shouval DS, Kanegane H, Kim KM, de Ridder L, Shah N, Ling G, Yerushalmi B, Kotlarz D, Snapper S, Horn R, Klein C, Muise AM, Huang Y, Uhlig HH. Predictive Prenatal Diagnosis for Infantile-onset Inflammatory Bowel Disease Because of Interleukin-10 Signalling Defects. J Pediatr Gastroenterol Nutr 2021;72:276-81. [PMID: 32925557 DOI: 10.1097/MPG.0000000000002937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Castagnoli R, Pala F, Bosticardo M, Licari A, Delmonte OM, Villa A, Marseglia GL, Notarangelo LD. Gut Microbiota-Host Interactions in Inborn Errors of Immunity. Int J Mol Sci 2021;22:1416. [PMID: 33572538 DOI: 10.3390/ijms22031416] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
52 Hübenthal M, Löscher BS, Erdmann J, Franke A, Gola D, König IR, Emmert H. Current Developments of Clinical Sequencing and the Clinical Utility of Polygenic Risk Scores in Inflammatory Diseases. Front Immunol 2020;11:577677. [PMID: 33633722 DOI: 10.3389/fimmu.2020.577677] [Reference Citation Analysis]
53 Taniguchi K, Inoue M, Arai K, Uchida K, Migita O, Akemoto Y, Hirayama J, Takeuchi I, Shimizu H, Hata K. Novel TNFAIP3 microdeletion in a girl with infantile-onset inflammatory bowel disease complicated by a severe perianal lesion. Hum Genome Var 2021;8:1. [PMID: 33446651 DOI: 10.1038/s41439-020-00128-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Misselwitz B, Wyss A, Raselli T, Cerovic V, Sailer AW, Krupka N, Ruiz F, Pot C, Pabst O. The oxysterol receptor GPR183 in inflammatory bowel diseases. Br J Pharmacol 2021;178:3140-56. [PMID: 33145756 DOI: 10.1111/bph.15311] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
55 Sens J, Hoffmann D, Lange L, Vollmer Barbosa P, Morgan M, Falk CS, Schambach A. Knockout-Induced Pluripotent Stem Cells for Disease and Therapy Modeling of IL-10-Associated Primary Immunodeficiencies. Hum Gene Ther 2021;32:77-95. [PMID: 33023317 DOI: 10.1089/hum.2020.235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
56 Su W, Yu Y, Xu X, Wang XQ, Huang JB, Xu CD, Xiao Y. Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases. World J Gastroenterol 2021; 27(1): 92-106 [PMID: 33505153 DOI: 10.3748/wjg.v27.i1.92] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
57 Wittmann Dayagi T, Werner L, Pinsker M, Salamon N, Barschak I, Weiss B, Shouval DS. Mucosal IL-10 and IL-10 receptor expression patterns in paediatric patients with ulcerative colitis. Int J Exp Pathol 2021;102:4-10. [PMID: 33405352 DOI: 10.1111/iep.12382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Troilo A, Frede N, Della Bella C, D’elios MM. Gut Involvement in Cellular Immunodeficiencies. Cellular Primary Immunodeficiencies 2021. [DOI: 10.1007/978-3-030-70107-9_13] [Reference Citation Analysis]
59 Ouahed J, Snapper S, Fuss I, Bousvaros A. Gastrointestinal Manifestations of Immunodeficiency. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00040-2] [Reference Citation Analysis]
60 Gans MD, Eisenberg R. Immune Dysregulation Leading to Autoimmunity. Primary and Secondary Immunodeficiency 2021. [DOI: 10.1007/978-3-030-57157-3_14] [Reference Citation Analysis]
61 Dotson JL, Boyle B. Crohn Disease. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00042-6] [Reference Citation Analysis]
62 Abolhassani H, Dabbaghzadeh A, Ahanchian H, Khalighi N, Ghaffari J, Ehlayel M, Espanol T, Crimi RD, Agulló PL, Niehues T. Diseases of immune dysregulation. Inborn Errors of Immunity 2021. [DOI: 10.1016/b978-0-12-821028-4.00005-1] [Reference Citation Analysis]
63 Wu WH, Zegarra-Ruiz DF, Diehl GE. Intestinal Microbes in Autoimmune and Inflammatory Disease. Front Immunol 2020;11:597966. [PMID: 33424846 DOI: 10.3389/fimmu.2020.597966] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
64 Liao ZQ, Ji QF, Zhou BJ. Strategies for inflammatory bowel disease drug research by targeting gut microbiota. Shijie Huaren Xiaohua Zazhi 2020; 28(22): 1112-1120 [DOI: 10.11569/wcjd.v28.i22.1112] [Reference Citation Analysis]
65 Ashton JJ, Boukas K, Davies J, Stafford IS, Vallejo AF, Haggarty R, Coelho TAF, Batra A, Afzal NA, Vadgama B, Williams AP, Beattie RM, Polak ME, Ennis S. Ileal Transcriptomic Analysis in Paediatric Crohn's Disease Reveals IL17- and NOD-signalling Expression Signatures in Treatment-naïve Patients and Identifies Epithelial Cells Driving Differentially Expressed Genes. J Crohns Colitis 2021;15:774-86. [PMID: 33232439 DOI: 10.1093/ecco-jcc/jjaa236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
66 Mallikarjunappa S, Shandilya UK, Sharma A, Lamers K, Bissonnette N, Karrow NA, Meade KG. Functional analysis of bovine interleukin-10 receptor alpha in response to Mycobacterium avium subsp. paratuberculosis lysate using CRISPR/Cas9. BMC Genet 2020;21:121. [PMID: 33138773 DOI: 10.1186/s12863-020-00925-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
67 de Mesquita MB, Shouval DS. Evaluation of very early-onset inflammatory bowel disease. Curr Opin Gastroenterol 2020;36:464-9. [PMID: 32868508 DOI: 10.1097/MOG.0000000000000680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
68 Cassinotti A, Passamonti F, Segato S. CELL THERAPY IN INFLAMMATORY BOWEL DISEASE. Pharmacol Res 2021;163:105247. [PMID: 33069755 DOI: 10.1016/j.phrs.2020.105247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
69 Hwang J, Jin J, Jeon S, Moon SH, Park MY, Yum DY, Kim JH, Kang JE, Park MH, Kim EJ, Pan JG, Kwon O, Oh GT. SOD1 suppresses pro-inflammatory immune responses by protecting against oxidative stress in colitis. Redox Biol 2020;37:101760. [PMID: 33096425 DOI: 10.1016/j.redox.2020.101760] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 8.7] [Reference Citation Analysis]
70 Liu CY, Tam SS, Huang Y, Dubé PE, Alhosh R, Girish N, Punit S, Nataneli S, Li F, Bender JM, Washington MK, Polk DB. TNF Receptor 1 Promotes Early-Life Immunity and Protects against Colitis in Mice. Cell Rep 2020;33:108275. [PMID: 33086075 DOI: 10.1016/j.celrep.2020.108275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
71 Salvador-Martín S, Bossacoma F, Pujol-Muncunill G, Navas-López VM, Gallego-Fernández C, Viada J, Muñoz-Codoceo R, Magallares L, Martínez-Ojinaga E, Moreno-Álvarez A, Solar-Boga A, Segarra O, Clemente S, Rodriguez-Martinez A, Alvarez-Vayo C, Loverdos I, Merino-Bohórquez V, Balboa-Vega MJ, Blanca-García JA, Fobelo MJ, Millán-Jiménez A, García-Romero R, Sanchez C, Tolín M, Caldas RG, Eizaguirre FJ, Sánchez-Hernandez JG, Torres-Peral R, Aznal E, García-González X, Sanjurjo-Sáez M, López-Fernández LA. Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:508-15. [PMID: 32773718 DOI: 10.1097/MPG.0000000000002840] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
72 Ruder B, Becker C. At the Forefront of the Mucosal Barrier: The Role of Macrophages in the Intestine. Cells 2020;9:E2162. [PMID: 32987848 DOI: 10.3390/cells9102162] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
73 Sato N, Garcia-Castillo V, Yuzawa M, Islam MA, Albarracin L, Tomokiyo M, Ikeda-Ohtsubo W, Garcia-Cancino A, Takahashi H, Villena J, Kitazawa H. Immunobiotic Lactobacillus jensenii TL2937 Alleviates Dextran Sodium Sulfate-Induced Colitis by Differentially Modulating the Transcriptomic Response of Intestinal Epithelial Cells. Front Immunol. 2020;11:2174. [PMID: 33042131 DOI: 10.3389/fimmu.2020.02174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Posovszky C, Barth TFE. [The gut: center of immunity : Rare inflammatory bowel diseases caused by immunodeficiencies]. Pathologe 2020;41:211-23. [PMID: 32253499 DOI: 10.1007/s00292-020-00775-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Atreya R, Neurath MF, Siegmund B. Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF? Front Med (Lausanne) 2020;7:517. [PMID: 32984386 DOI: 10.3389/fmed.2020.00517] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
76 Kheder M, Behfar M, Farajifard H, Ali T, Hkima Abou Fakher F, Hamidieh AA. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in pediatric patient with IL10 receptor deficiency. Pediatr Transplant 2021;25:e13819. [PMID: 32845546 DOI: 10.1111/petr.13819] [Reference Citation Analysis]
77 Mollaei M, Abbasi A, Hassan ZM, Pakravan N. The intrinsic and extrinsic elements regulating inflammation. Life Sci 2020;260:118258. [PMID: 32818542 DOI: 10.1016/j.lfs.2020.118258] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
78 Charlet R, Bortolus C, Sendid B, Jawhara S. Bacteroides thetaiotaomicron and Lactobacillus johnsonii modulate intestinal inflammation and eliminate fungi via enzymatic hydrolysis of the fungal cell wall. Sci Rep 2020;10:11510. [PMID: 32661259 DOI: 10.1038/s41598-020-68214-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
79 Rahmani F, Rayzan E, Rahmani MR, Shahkarami S, Zoghi S, Rezaei A, Aryan Z, Najafi M, Rohlfs M, Jeske T, Aflatoonian M, Chavoshzadeh Z, Farahmand F, Motamed F, Rohani P, Alimadadi H, Mahdaviani A, Mansouri M, Tavakol M, Vanderberg M, Kotlarz D, Klein C, Rezaei N. Clinical and Mutation Description of the First Iranian Cohort of Infantile Inflammatory Bowel Disease: The Iranian Primary Immunodeficiency Registry (IPIDR). Immunol Invest 2021;50:445-59. [PMID: 32633164 DOI: 10.1080/08820139.2020.1776725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
80 Wachs AS, Bohne J. Two sides of the same medal: Noncoding mutations reveal new pathological mechanisms and insights into the regulation of gene expression. Wiley Interdiscip Rev RNA 2021;12:e1616. [PMID: 32633083 DOI: 10.1002/wrna.1616] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Wang L, Xue A, Zheng C, Zhou Y, Wang Y, Huang Y. Long-term outcomes of thalidomide in pediatric Crohn's disease. J Gastroenterol Hepatol 2020;35:1124-9. [PMID: 31758718 DOI: 10.1111/jgh.14939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
82 Lee WI, Huang JL, Lin SJ, Yeh KW, Chen LC, Ou LS, Yao TC, Jaing TH, Shih YF, Wu CY. Lower T Regulatory and Th17 Cell Populations Predicted by RT-PCR-Amplified FOXP3 and RORγt Genes Are Not Rare in Patients With Primary Immunodeficiency Diseases. Front Immunol 2020;11:1111. [PMID: 32670274 DOI: 10.3389/fimmu.2020.01111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
83 Koelink PJ, Bloemendaal FM, Li B, Westera L, Vogels EWM, van Roest M, Gloudemans AK, van 't Wout AB, Korf H, Vermeire S, Te Velde AA, Ponsioen CY, D'Haens GR, Verbeek JS, Geiger TL, Wildenberg ME, van den Brink GR. Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling. Gut 2020;69:1053-63. [PMID: 31506328 DOI: 10.1136/gutjnl-2019-318264] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 19.7] [Reference Citation Analysis]
84 Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, Field M, Grushkin-Lerner L, Pai SY, Bousvaros A, Cho J, Argmann C, Schadt E, Mcgovern DPB, Mokry M, Nieuwenhuis E, Clevers H, Powrie F, Uhlig H, Klein C, Muise A, Dubinsky M, Snapper SB. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis 2020;26:820-42. [PMID: 31833544 DOI: 10.1093/ibd/izz259] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 17.7] [Reference Citation Analysis]
85 Silva NOE, de Brito BB, da Silva FAF, Santos MLC, de Melo FF. Probiotics in inflammatory bowel disease: Does it work? World J Meta-Anal 2020; 8(2): 54-66 [DOI: 10.13105/wjma.v8.i2.54] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
86 Poddar U, Yachha SK, Srivastava A, Kumari N. Pediatric inflammatory bowel disease: Is it really uncommon in Asian children? JGH Open 2020;4:860-6. [PMID: 33102756 DOI: 10.1002/jgh3.12330] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Samiea A, Yoon JSJ, Cheung ST, Chamberlain TC, Mui AL. Interleukin-10 contributes to PGE2 signalling through upregulation of EP4 via SHIP1 and STAT3. PLoS One 2020;15:e0230427. [PMID: 32240179 DOI: 10.1371/journal.pone.0230427] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
88 Kelsen JR, Sullivan KE, Rabizadeh S, Singh N, Snapper S, Elkadri A, Grossman AB. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Evaluation and Management for Patients With Very Early-onset Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;70:389-403. [PMID: 32079889 DOI: 10.1097/MPG.0000000000002567] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 16.3] [Reference Citation Analysis]
89 Dang PM, Rolas L, El-Benna J. The Dual Role of Reactive Oxygen Species-Generating Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Gastrointestinal Inflammation and Therapeutic Perspectives. Antioxid Redox Signal 2020;33:354-73. [PMID: 31968991 DOI: 10.1089/ars.2020.8018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
90 Hartono S, Ippoliti MR, Mastroianni M, Torres R, Rider NL. Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases. Clin Rev Allergy Immunol 2019;57:145-65. [PMID: 29754192 DOI: 10.1007/s12016-018-8689-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
91 Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep 2020;47:3053-63. [PMID: 32086718 DOI: 10.1007/s11033-020-05318-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
92 Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-polo M, Zaki FM, Navarro OM. Autoinflammatory diseases in childhood, part 1: monogenic syndromes. Pediatr Radiol 2020;50:415-30. [DOI: 10.1007/s00247-019-04536-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
93 Rees WD, Sly LM, Steiner TS. How do immune and mesenchymal cells influence the intestinal epithelial cell compartment in inflammatory bowel disease? Let's crosstalk about it! J Leukoc Biol 2020;108:309-21. [PMID: 32057139 DOI: 10.1002/JLB.3MIR0120-567R] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
94 Werner L, Lee YN, Rechavi E, Lev A, Yerushalmi B, Ling G, Shah N, Uhlig HH, Weiss B, Somech R, Snapper SB, Shouval DS. Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD. Front Immunol 2020;11:109. [PMID: 32117262 DOI: 10.3389/fimmu.2020.00109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
95 Basso L, Benamar M, Mas‐orea X, Deraison C, Blanpied C, Cenac N, Saoudi A, Dietrich G. Endogenous control of inflammatory visceral pain by T cell‐derived opioids in IL‐10‐deficient mice. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13743] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
96 Tang Z, Huang Z, Yan W, Zhang Y, Shi P, Dong K, Gong Y, Ji M, Wang Y, Yu Z, Huang Y. Complications of enterostomy and related risk factor analysis of very early onset inflammatory bowel disease with interleukin-10 signalling deficiency: a single-centre retrospective analysis. BMC Gastroenterol 2020;20:8. [PMID: 31931724 DOI: 10.1186/s12876-020-1160-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Griffiths OR, Landon J, Coxon RE, Morris K, James P, Adams R. Inflammatory bowel disease and targeted oral anti-TNFα therapy. Adv Protein Chem Struct Biol 2020;119:157-98. [PMID: 31997768 DOI: 10.1016/bs.apcsb.2019.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
98 Digby-Bell JL, Atreya R, Monteleone G, Powell N. Interrogating host immunity to predict treatment response in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:9-20. [PMID: 31767987 DOI: 10.1038/s41575-019-0228-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 18.0] [Reference Citation Analysis]
99 Lv H, Qiao B, Fang L, Yang L, Wang Q, Wu S, Ren P, Li L. Neonatal Crohn's disease with Oral ulcer as the first symptom caused by a compound heterozygote mutation in IL-10RA: a case report. Hereditas 2019;156:38. [PMID: 31889944 DOI: 10.1186/s41065-019-0114-8] [Reference Citation Analysis]
100 Diaz OE, Morales RA, Das S, Villablanca EJ. Experimental Models of Intestinal Inflammation: Lessons from Mouse and Zebrafish. In: Hedin C, Rioux JD, D'amato M, editors. Molecular Genetics of Inflammatory Bowel Disease. Cham: Springer International Publishing; 2019. pp. 47-76. [DOI: 10.1007/978-3-030-28703-0_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
101 Zirakzadeh AA, Sherif A, Rosenblatt R, Ahlén Bergman E, Winerdal M, Yang D, Cederwall J, Jakobsson V, Hyllienmark M, Winqvist O, Marits P. Tumour-associated B cells in urothelial urinary bladder cancer. Scand J Immunol 2020;91:e12830. [PMID: 31823416 DOI: 10.1111/sji.12830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
102 Ozen A. CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann's disease. Immunol Rev 2019;287:20-32. [PMID: 30565236 DOI: 10.1111/imr.12715] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
103 Abdel-Motal UM, Al-Shaibi A, Elawad M, Lo B. Zero tolerance! A perspective on monogenic disorders with defective regulatory T cells and IBD-like disease. Immunol Rev 2019;287:236-40. [PMID: 30565246 DOI: 10.1111/imr.12717] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
104 Scott NA, Mann ER. Regulation of mononuclear phagocyte function by the microbiota at mucosal sites. Immunology 2020;159:26-38. [PMID: 31777068 DOI: 10.1111/imm.13155] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
105 Bakhtiar S, Fekadu J, Seidel MG, Gambineri E. Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders. Front Pediatr 2019;7:461. [PMID: 31799221 DOI: 10.3389/fped.2019.00461] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
106 Neumann C, Scheffold A, Rutz S. Functions and regulation of T cell-derived interleukin-10. Semin Immunol 2019;44:101344. [PMID: 31727465 DOI: 10.1016/j.smim.2019.101344] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 14.5] [Reference Citation Analysis]
107 Magg T, Shcherbina A, Arslan D, Desai MM, Wall S, Mitsialis V, Conca R, Unal E, Karacabey N, Mukhina A, Rodina Y, Taur PD, Illig D, Marquardt B, Hollizeck S, Jeske T, Gothe F, Schober T, Rohlfs M, Koletzko S, Lurz E, Muise AM, Snapper SB, Hauck F, Klein C, Kotlarz D. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1788-95. [PMID: 31115454 DOI: 10.1093/ibd/izz103] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
108 Zhang P, Hill GR. Interleukin-10 mediated immune regulation after stem cell transplantation: Mechanisms and implications for therapeutic intervention. Semin Immunol 2019;44:101322. [PMID: 31640914 DOI: 10.1016/j.smim.2019.101322] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
109 Cepika AM, Sato Y, Liu JM, Uyeda MJ, Bacchetta R, Roncarolo MG. Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency. J Allergy Clin Immunol. 2018;142:1679-1695. [PMID: 30527062 DOI: 10.1016/j.jaci.2018.10.026] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 17.8] [Reference Citation Analysis]
110 Wang C, Baer HM, Gaya DR, Nibbs RJB, Milling S. Can molecular stratification improve the treatment of inflammatory bowel disease? Pharmacol Res 2019;148:104442. [PMID: 31491469 DOI: 10.1016/j.phrs.2019.104442] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
111 Khoshnevisan R, Vakili F, Klein C, Kotlarz D, Nasirian M, Sherkat R, Rezaei A. An analysis and survey of interleukin-10 receptor mutation in inflammatory bowel disease (IBD) in the first Iranian IBD cohort. Journal of Laboratory Medicine 2019;43:185-9. [DOI: 10.1515/labmed-2019-0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Veenbergen S, Li P, Raatgeep HC, Lindenbergh-Kortleve DJ, Simons-Oosterhuis Y, Farrel A, Costes LMM, Joosse ME, van Berkel LA, de Ruiter LF, van Leeuwen MA, Winter D, Holland SM, Freeman AF, Wakabayashi Y, Zhu J, de Ridder L, Driessen GJ, Escher JC, Leonard WJ, Samsom JN. IL-10 signaling in dendritic cells controls IL-1β-mediated IFNγ secretion by human CD4+ T cells: relevance to inflammatory bowel disease. Mucosal Immunol 2019;12:1201-11. [PMID: 31417161 DOI: 10.1038/s41385-019-0194-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
113 Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol 2019;20:970-9. [PMID: 31235952 DOI: 10.1038/s41590-019-0415-0] [Cited by in Crossref: 248] [Cited by in F6Publishing: 260] [Article Influence: 62.0] [Reference Citation Analysis]
114 Schwimmer D, Glover S. Primary Immunodeficiency and the Gut. Gastroenterol Clin North Am 2019;48:199-220. [PMID: 31046971 DOI: 10.1016/j.gtc.2019.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
115 Yazdani R, Moazzami B, Madani SP, Behniafard N, Azizi G, Aflatoonian M, Abolhassani H, Aghamohammadi A. Candidiasis associated with very early onset inflammatory bowel disease: First IL10RB deficient case from the National Iranian Registry and review of the literature. Clin Immunol 2019;205:35-42. [PMID: 31096038 DOI: 10.1016/j.clim.2019.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
116 Sun S, Ye Z, Zheng S, Chen G, Qian X, Dong K, Huang Y. Surgical treatment of monogenic inflammatory bowel disease: A single clinical center experience. J Pediatr Surg 2019;54:2155-61. [PMID: 31027905 DOI: 10.1016/j.jpedsurg.2019.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
117 Teng X, Xu L, Sun M, Guo J. Phenotypic characteristics and clinical manifestations of inflammatory bowel disease in infants and children under 2 years of age in Liaoning Province, China: five of six infants with IL-10R mutations. Paediatr Int Child Health 2019;39:59-64. [PMID: 30900524 DOI: 10.1080/20469047.2018.1560700] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Zheng C, Huang Y, Hu W, Shi J, Ye Z, Qian X, Huang Z, Xue A, Wang Y, Lu J, Tang Z, Wu J, Wang L, Peng K, Zhou Y, Miao S, Sun H. Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study. Inflamm Bowel Dis 2019;25:756-66. [PMID: 30212871 DOI: 10.1093/ibd/izy289] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
119 Almana Y, Mohammed R. Current concepts in pediatric inflammatory bowel disease; IL10/IL10R colitis as a model disease. Int J Pediatr Adolesc Med 2019;6:1-5. [PMID: 31304220 DOI: 10.1016/j.ijpam.2019.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
120 Tomkovich S, Dejea CM, Winglee K, Drewes JL, Chung L, Housseau F, Pope JL, Gauthier J, Sun X, Mühlbauer M, Liu X, Fathi P, Anders RA, Besharati S, Perez-Chanona E, Yang Y, Ding H, Wu X, Wu S, White JR, Gharaibeh RZ, Fodor AA, Wang H, Pardoll DM, Jobin C, Sears CL. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic. J Clin Invest 2019;129:1699-712. [PMID: 30855275 DOI: 10.1172/JCI124196] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 25.3] [Reference Citation Analysis]
121 Simčič S, Berlec A, Stopinšek S, Štrukelj B, Orel R. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa. World J Microbiol Biotechnol 2019;35:45. [PMID: 30810891 DOI: 10.1007/s11274-019-2615-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
122 Oh SH, Sung YH, Kim I, Sim CK, Lee JH, Baek M, Pack CG, Seok C, Seo EJ, Lee MS, Kim KM. Novel Compound Heterozygote Mutation in IL10RA in a Patient With Very Early-Onset Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:498-509. [PMID: 30462267 DOI: 10.1093/ibd/izy353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
123 Haas OA. Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework. Front Immunol 2018;9:3136. [PMID: 30809233 DOI: 10.3389/fimmu.2018.03136] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
124 Wyss A, Raselli T, Perkins N, Ruiz F, Schmelczer G, Klinke G, Moncsek A, Roth R, Spalinger MR, Hering L, Atrott K, Lang S, Frey-Wagner I, Mertens JC, Scharl M, Sailer AW, Pabst O, Hersberger M, Pot C, Rogler G, Misselwitz B. The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis. Mucosal Immunol 2019;12:733-45. [PMID: 30742043 DOI: 10.1038/s41385-019-0140-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
125 Lipinski S, Petersen BS, Barann M, Piecyk A, Tran F, Mayr G, Jentzsch M, Aden K, Stengel ST, Klostermeier UC, Sheth V, Ellinghaus D, Rausch T, Korbel JO, Nothnagel M, Krawczak M, Gilissen C, Veltman JA, Forster M, Forster P, Lee CC, Fritscher-Ravens A, Schreiber S, Franke A, Rosenstiel P. Missense variants in NOX1 and p22phox in a case of very-early-onset inflammatory bowel disease are functionally linked to NOD2. Cold Spring Harb Mol Case Stud 2019;5:a002428. [PMID: 30709874 DOI: 10.1101/mcs.a002428] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
126 Shim JO. Recent Advance in Very Early Onset Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2019;22:41-9. [PMID: 30671372 DOI: 10.5223/pghn.2019.22.1.41] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
127 Schulert GS. Immunology of Auto-inflammatory Syndromes. Auto-Inflammatory Syndromes 2019. [DOI: 10.1007/978-3-319-96929-9_1] [Reference Citation Analysis]
128 Muise AM. Very Early Onset Inflammatory Bowel Disease (VEOIBD). Textbook of Autoinflammation 2019. [DOI: 10.1007/978-3-319-98605-0_21] [Reference Citation Analysis]
129 Kocacik Uygun DF, Uygun V, Daloğlu H, Öztürkmen S, Karasu G, Reisli İ, Sayar E, Yüksekkaya HA, Glocker E, Boztuğ K, Yeşilipek A. Hematopoietic Stem Cell Transplantation From Unrelated Donors in 2 Cases of Interleukin-10 Receptor Deficiency: Is Surgery Not a Requirement? Journal of Pediatric Hematology/Oncology 2019;41:64-6. [DOI: 10.1097/mph.0000000000001165] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
130 Karaca NE, Aksu G, Kutukculer N. Early-Onset Inflammatory Bowel Disease. Pediatric Immunology 2019. [DOI: 10.1007/978-3-030-21262-9_95] [Reference Citation Analysis]
131 Muise A, Huang H. Sequencing and Mapping IBD Genes to Individual Causative Variants and Their Clinical Relevance. Molecular Genetics of Inflammatory Bowel Disease 2019. [DOI: 10.1007/978-3-030-28703-0_6] [Reference Citation Analysis]
132 Goldbach-mansky R, de Jesus AA. Classification of Genetically Defined Autoinflammatory Diseases. Textbook of Autoinflammation 2019. [DOI: 10.1007/978-3-319-98605-0_10] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
133 Haas OA, Borkhardt A. Genetic Predisposition to Non-Hodgkin Lymphoma. Non-Hodgkin's Lymphoma in Childhood and Adolescence 2019. [DOI: 10.1007/978-3-030-11769-6_8] [Reference Citation Analysis]
134 Brockmann L, Soukou S, Steglich B, Czarnewski P, Zhao L, Wende S, Bedke T, Ergen C, Manthey C, Agalioti T, Geffken M, Seiz O, Parigi SM, Sorini C, Geginat J, Fujio K, Jacobs T, Roesch T, Izbicki JR, Lohse AW, Flavell RA, Krebs C, Gustafsson JA, Antonson P, Roncarolo MG, Villablanca EJ, Gagliani N, Huber S. Molecular and functional heterogeneity of IL-10-producing CD4+ T cells. Nat Commun 2018;9:5457. [PMID: 30575716 DOI: 10.1038/s41467-018-07581-4] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 11.8] [Reference Citation Analysis]
135 Jung ES, Petersen BS, Mayr G, Cheon JH, Kang Y, Lee SJ, Che X, Kim WH, Kim S, Schreiber S, Franke A, Koh H. Compound heterozygous mutations in IL10RA combined with a complement factor properdin mutation in infantile-onset inflammatory bowel disease. Eur J Gastroenterol Hepatol 2018;30:1491-6. [PMID: 30199474 DOI: 10.1097/MEG.0000000000001247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
136 Worley L, Tangye SG, Ma CS. What can primary immunodeficiencies teach us about Th9 cell differentiation and function? Immunol Cell Biol 2019;97:380-8. [PMID: 30357921 DOI: 10.1111/imcb.12215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
137 Shim JO. Recent advance in very early-onset inflammatory bowel disease. Intest Res 2019;17:9-16. [PMID: 30419637 DOI: 10.5217/ir.2018.00130] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
138 Zaidi D, Wine E. Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases. Front Pediatr 2018;6:317. [PMID: 30425977 DOI: 10.3389/fped.2018.00317] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
139 Charbit-Henrion F, Bègue B, Sierra A, Hanein S, Stolzenberg MC, Li Z, Pellegrini S, Garcelon N, Jeanpierre M, Neven B, Loge I, Picard C, Rosain J, Bustamante J, Le Lorc'h M, Pigneur B, Fernandes A, Rieux-Laucat F, Amil Dias J, Ruemmele FM, Cerf-Bensussan N; GENIUS Group. Copy number variations and founder effect underlying complete IL-10Rβ deficiency in Portuguese kindreds. PLoS One 2018;13:e0205826. [PMID: 30365510 DOI: 10.1371/journal.pone.0205826] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
140 Wyss A, Raselli T, Schmelczer G, Klinke G, Perkins N, Hersberger M, Spalinger MR, Atrott K, Lang S, Frey-wagner I, Scharl M, Sailer AW, Pabst O, Rogler G, Misselwitz B. The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis.. [DOI: 10.1101/424937] [Reference Citation Analysis]
141 Moghaddas F, Masters SL. The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders. Clin Sci (Lond) 2018;132:1901-24. [PMID: 30185613 DOI: 10.1042/CS20171498] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
142 Barber J, Shah N, Watson T. Early onset inflammatory bowel disease – What the radiologist needs to know. European Journal of Radiology 2018;106:173-82. [DOI: 10.1016/j.ejrad.2018.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
143 Danne C, Ryzhakov G, Martínez-López M, Ilott NE, Franchini F, Cuskin F, Lowe EC, Bullers SJ, Arthur JSC, Powrie F. A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages. Cell Host Microbe 2017;22:733-745.e5. [PMID: 29241040 DOI: 10.1016/j.chom.2017.11.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 12.2] [Reference Citation Analysis]
144 Mitchell J, Kim SJ, Koukos G, Seelmann A, Veit B, Shepard B, Blumer-Schuette S, Winter HS, Iliopoulos D, Pothoulakis C, Im E, Rhee SH. Colonic Inhibition of Phosphatase and Tensin Homolog Increases Colitogenic Bacteria, Causing Development of Colitis in Il10-/- Mice. Inflamm Bowel Dis 2018;24:1718-32. [PMID: 29788382 DOI: 10.1093/ibd/izy124] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
145 Shouval DS, Kowalik M, Snapper SB. The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies. J Clin Immunol 2018;38:579-88. [DOI: 10.1007/s10875-018-0524-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
146 Troncone E, Marafini I, Stolfi C, Monteleone G. Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer. Front Immunol 2018;9:1407. [PMID: 29973939 DOI: 10.3389/fimmu.2018.01407] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
147 Peng K, Qian X, Huang Z, Lu J, Wang Y, Zhou Y, Wang H, Wu B, Wang Y, Chen L, Zhai X, Huang Y. Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency. Inflamm Bowel Dis 2018;24:1416-27. [PMID: 29788474 DOI: 10.1093/ibd/izy028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
148 Amininejad L, Charloteaux B, Theatre E, Liefferinckx C, Dmitrieva J, Hayard P, Muls V, Maisin JM, Schapira M, Ghislain JM, Closset P, Talib M, Abramowicz M, Momozawa Y, Deffontaine V, Crins F, Mni M, Karim L, Cambisano N, Ornemese S, Zucchi A, Minsart C, Deviere J, Hugot JP, De Vos M, Louis E, Vermeire S, Van Gossum A, Coppieters W, Twizere JC, Georges M, Franchimont D; International IBD Genetics Consortium. Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease. Gastroenterology 2018;154:2165-77. [PMID: 29501442 DOI: 10.1053/j.gastro.2018.02.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
149 Takahashi R, Noguchi T, Mizoguchi Y, Shimoyama T, Nakazawa T, Ikuta T. A Synbiotic with Tumor Necrosis Factor-α Inhibitory Activity Ameliorates Experimental Jejunoileal Mucosal Injury. Biomed Res Int 2018;2018:9184093. [PMID: 29862296 DOI: 10.1155/2018/9184093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
150 Nunberg MY, Werner L, Kopylov U, Haberman Y, Lahad A, Weiss B, Shouval DS. Impaired IL-10 Receptor-mediated Suppression in Monocyte From Patients With Crohn Disease. J Pediatr Gastroenterol Nutr 2018;66:779-84. [PMID: 29045353 DOI: 10.1097/MPG.0000000000001795] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
151 Eichenberger RM, Ryan S, Jones L, Buitrago G, Polster R, Montes de Oca M, Zuvelek J, Giacomin PR, Dent LA, Engwerda CR, Field MA, Sotillo J, Loukas A. Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice. Front Immunol 2018;9:850. [PMID: 29760697 DOI: 10.3389/fimmu.2018.00850] [Cited by in Crossref: 116] [Cited by in F6Publishing: 119] [Article Influence: 23.2] [Reference Citation Analysis]
152 Al-Abbasi FA, Mohammed K, Sadath S, Banaganapalli B, Nasser K, Shaik NA. Computational Protein Phenotype Characterization of IL10RA Mutations Causative to Early Onset Inflammatory Bowel Disease (IBD). Front Genet 2018;9:146. [PMID: 29755507 DOI: 10.3389/fgene.2018.00146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
153 Ahluwalia B, Moraes L, Magnusson MK, Öhman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol 2018;53:379-89. [PMID: 29523023 DOI: 10.1080/00365521.2018.1447597] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 18.0] [Reference Citation Analysis]
154 Lyons JJ, Milner JD. Primary atopic disorders. J Exp Med 2018;215:1009-22. [PMID: 29549114 DOI: 10.1084/jem.20172306] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
155 Kotlarz D, Marquardt B, Barøy T, Lee WS, Konnikova L, Hollizeck S, Magg T, Lehle AS, Walz C, Borggraefe I, Hauck F, Bufler P, Conca R, Wall SM, Schumacher EM, Misceo D, Frengen E, Bentsen BS, Uhlig HH, Hopfner KP, Muise AM, Snapper SB, Strømme P, Klein C. Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy. Nat Genet 2018;50:344-8. [PMID: 29483653 DOI: 10.1038/s41588-018-0063-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 15.0] [Reference Citation Analysis]
156 Deenick EK, Pelham SJ, Kane A, Ma CS. Signal Transducer and Activator of Transcription 3 Control of Human T and B Cell Responses. Front Immunol 2018;9:168. [PMID: 29472924 DOI: 10.3389/fimmu.2018.00168] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
157 Kim KY, Lee EJ, Kim JW, Moon JS, Jang JY, Yang HR, Ko JS. Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2018;21:34-42. [PMID: 29383303 DOI: 10.5223/pghn.2018.21.1.34] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
158 Dai W, Ye Z, Lu H, Su Q, Li H, Li L. Meta-analysis of the relationship between single nucleotide polymorphism of IL-10-1082G/A and rheumatic heart disease. Oncotarget 2018;9:12343-50. [PMID: 29552315 DOI: 10.18632/oncotarget.23901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
159 Elkadri AA, Muise A. Inflammatory Bowel Disease in Primary Immunodeficiencies. Management of Infections in the Immunocompromised Host 2018. [DOI: 10.1007/978-3-319-77674-3_9] [Reference Citation Analysis]
160 Liu CY, Polk DB, Frey MR. Mucosal Restitution and Repair. Physiology of the Gastrointestinal Tract 2018. [DOI: 10.1016/b978-0-12-809954-4.00029-3] [Reference Citation Analysis]
161 Chang S, Shen B. Classification and Reclassification of Inflammatory Bowel Diseases. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications 2018. [DOI: 10.1016/b978-0-12-811388-2.00002-6] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
162 Girard-Madoux MJ, Ober-Blöbaum JL, Costes LM, Kel JM, Lindenbergh-Kortleve DJ, Brouwers-Haspels I, Heikema AP, Samsom JN, Clausen BE. IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine. Oncotarget 2016;7:32015-30. [PMID: 27027442 DOI: 10.18632/oncotarget.8337] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
163 Ye Z, Zhou Y, Huang Y, Wang Y, Lu J, Tang Z, Miao S, Dong K, Jiang Z. Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China. Inflamm Bowel Dis 2017;23:2154-64. [PMID: 29140941 DOI: 10.1097/MIB.0000000000001269] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
164 Salem GA, Selby GB. Stem cell transplant in inflammatory bowel disease: a promising modality of treatment for a complicated disease course. Stem Cell Investig 2017;4:95. [PMID: 29270421 DOI: 10.21037/sci.2017.11.04] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
165 Schwerd T, Uhlig HH. Chronisch-entzündliche Darmerkrankung und Immundefekte: Klinische Präsentationen und diagnostische Möglichkeiten. Monatsschr Kinderheilkd 2017;165:1092-101. [DOI: 10.1007/s00112-017-0393-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Witkowski M, Witkowski M, Gagliani N, Huber S. Recipe for IBD: can we use food to control inflammatory bowel disease? Semin Immunopathol 2018;40:145-56. [PMID: 29124320 DOI: 10.1007/s00281-017-0658-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
167 Shouval DS, Konnikova L, Griffith AE, Wall SM, Biswas A, Werner L, Nunberg M, Kammermeier J, Goettel JA, Anand R, Chen H, Weiss B, Li J, Loizides A, Yerushalmi B, Yanagi T, Beier R, Conklin LS, Ebens CL, Santos FGMS, Sherlock M, Goldsmith JD, Kotlarz D, Glover SC, Shah N, Bousvaros A, Uhlig HH, Muise AM, Klein C, Snapper SB. Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. Inflamm Bowel Dis 2017;23:1950-61. [PMID: 29023267 DOI: 10.1097/MIB.0000000000001270] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
168 Tangye SG, Pelham SJ, Deenick EK, Ma CS. Cytokine-Mediated Regulation of Human Lymphocyte Development and Function: Insights from Primary Immunodeficiencies. J Immunol 2017;199:1949-58. [PMID: 28874415 DOI: 10.4049/jimmunol.1700842] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
169 Moran CJ. Very early onset inflammatory bowel disease. Semin Pediatr Surg 2017;26:356-9. [PMID: 29126503 DOI: 10.1053/j.sempedsurg.2017.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
170 Ferreira IB, Pickering DA, Troy S, Croese J, Loukas A, Navarro S. Suppression of inflammation and tissue damage by a hookworm recombinant protein in experimental colitis. Clin Transl Immunology 2017;6:e157. [PMID: 29114386 DOI: 10.1038/cti.2017.42] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
171 Lee C, Kim BG, Kim JH, Chun J, Im JP, Kim JS. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. International Immunopharmacology 2017;51:47-56. [DOI: 10.1016/j.intimp.2017.07.023] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 17.7] [Reference Citation Analysis]
172 López-García A, Rovira M, Jauregui-Amezaga A, Marín P, Barastegui R, Salas A, Ribas V, Feu F, Elizalde JI, Fernández-Avilés F, Martínez C, Gutiérrez G, Rosiñol L, Carreras E, Urbano A, Lozano M, Cid J, Suárez-Lledó M, Masamunt MC, Comas D, Giner A, Gallego M, Alfaro I, Ordás I, Panés J, Ricart E. Autologous Haematopoietic Stem Cell Transplantation for Refractory Crohn's Disease: Efficacy in a Single-Centre Cohort. J Crohns Colitis 2017;11:1161-8. [PMID: 28419282 DOI: 10.1093/ecco-jcc/jjx054] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
173 Ochs HD, Petroni D. From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disorders. Am J Med Genet 2018;176:784-803. [DOI: 10.1002/ajmg.a.38480] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
174 Lien R, Lin YF, Lai MW, Weng HY, Wu RC, Jaing TH, Huang JL, Tsai SF, Lee WI. Novel Mutations of the Tetratricopeptide Repeat Domain 7A Gene and Phenotype/Genotype Comparison. Front Immunol 2017;8:1066. [PMID: 28936210 DOI: 10.3389/fimmu.2017.01066] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
175 Nemati S, Teimourian S, Tabrizi M, Najafi M, Dara N, Imanzadeh F, Ahmadi M, Aghdam MK, Tavassoli M, Rohani P, Madani SR, de Boer M, Kuijpers TW, Roos D. Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children. Eur J Med Genet 2017;60:643-9. [PMID: 28864178 DOI: 10.1016/j.ejmg.2017.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
176 Broggi A, Tan Y, Granucci F, Zanoni I. IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function. Nat Immunol 2017;18:1084-93. [PMID: 28846084 DOI: 10.1038/ni.3821] [Cited by in Crossref: 147] [Cited by in F6Publishing: 146] [Article Influence: 24.5] [Reference Citation Analysis]
177 Tegtmeyer D, Seidl M, Gerner P, Baumann U, Klemann C. Inflammatory bowel disease caused by primary immunodeficiencies-Clinical presentations, review of literature, and proposal of a rational diagnostic algorithm. Pediatr Allergy Immunol 2017;28:412-29. [DOI: 10.1111/pai.12734] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
178 Uhlig HH, Muise AM. Clinical Genomics in Inflammatory Bowel Disease. Trends Genet. 2017;33:629-641. [PMID: 28755896 DOI: 10.1016/j.tig.2017.06.008] [Cited by in Crossref: 69] [Cited by in F6Publishing: 103] [Article Influence: 11.5] [Reference Citation Analysis]
179 Manthiram K, Zhou Q, Aksentijevich I, Kastner DL. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol 2017;18:832-42. [DOI: 10.1038/ni.3777] [Cited by in Crossref: 237] [Cited by in F6Publishing: 241] [Article Influence: 39.5] [Reference Citation Analysis]
180 Schmetterer KG, Pickl WF. The IL-10/STAT3 axis: Contributions to immune tolerance by thymus and peripherally derived regulatory T-cells. Eur J Immunol. 2017;47:1256-1265. [PMID: 28631311 DOI: 10.1002/eji.201646710] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 9.2] [Reference Citation Analysis]
181 Redhu NS, Bakthavatchalu V, Conaway EA, Shouval DS, Tsou A, Goettel JA, Biswas A, Wang C, Field M, Muller W, Bleich A, Li N, Gerber GK, Bry L, Fox JG, Snapper SB, Horwitz BH. Macrophage dysfunction initiates colitis during weaning of infant mice lacking the interleukin-10 receptor. Elife 2017;6:e27652. [PMID: 28678006 DOI: 10.7554/eLife.27652] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
182 Pal LR, Kundu K, Yin Y, Moult J. CAGI4 Crohn's exome challenge: Marker SNP vs exome variant models for assigning risk of Crohn disease. Hum Mutat. 2017;38:1225-1234. [PMID: 28512778 DOI: 10.1002/humu.23256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
183 Lee WI, Chen CC, Jaing TH, Ou LS, Hsueh C, Huang JL. A Nationwide Study of Severe and Protracted Diarrhoea in Patients with Primary Immunodeficiency Diseases. Sci Rep 2017;7:3669. [PMID: 28623282 DOI: 10.1038/s41598-017-03967-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
184 McDonald BS, Narayanan S, Elawad M, Kiparissi F, Cullup T, Batta K. Interleukin-10 receptor mutation presenting with severe nappy ulceration and infantile inflammatory bowel disease. Clin Exp Dermatol 2017;42:771-3. [PMID: 28597964 DOI: 10.1111/ced.13157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
185 Chandrakasan S, Venkateswaran S, Kugathasan S. Nonclassic Inflammatory Bowel Disease in Young Infants: Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome, and Other Disorders. Pediatr Clin North Am. 2017;64:139-160. [PMID: 27894441 DOI: 10.1016/j.pcl.2016.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
186 Bequet E, Sarter H, Fumery M, Vasseur F, Armengol-Debeir L, Pariente B, Ley D, Spyckerelle C, Coevoet H, Laberenne JE, Peyrin-Biroulet L, Savoye G, Turck D, Gower-Rousseau C; EPIMAD Group. Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]. J Crohns Colitis 2017;11:519-26. [PMID: 28453757 DOI: 10.1093/ecco-jcc/jjw194] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
187 Ricart E, López-garcía A, Barastegui R, Gallego M. Trasplante de médula ósea para el tratamiento de la enfermedad de Crohn refractaria. Enfermedad Inflamatoria Intestinal al Día 2017;16:70-76. [DOI: 10.1016/j.eii.2016.09.007] [Reference Citation Analysis]
188 Schwartz JS, Peres AG, Mfuna Endam L, Cousineau B, Madrenas J, Desrosiers M. Topical probiotics as a therapeutic alternative for chronic rhinosinusitis: A preclinical proof of concept. Am J Rhinol Allergy 2016;30:202-5. [PMID: 28124641 DOI: 10.2500/ajra.2016.30.4372] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
189 Zhu L, Shi T, Zhong C, Wang Y, Chang M, Liu X. IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease. Gastroenterology Res 2017;10:65-9. [PMID: 28496525 DOI: 10.14740/gr740w] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 10.2] [Reference Citation Analysis]
190 Huang Z, Peng K, Li X, Zhao R, You J, Cheng X, Wang Z, Wang Y, Wu B, Wang H, Zeng H, Yu Z, Zheng C, Wang Y, Huang Y. Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey. Inflamm Bowel Dis 2017;23:578-90. [PMID: 28267044 DOI: 10.1097/MIB.0000000000001058] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
191 Mandola AB, Eshel Y, Nahum A. A genetic database and clinical findings for immunodeficiency due to mutations in Interleukin -10, IL-10 Receptor A and IL-10 Receptor B genes. LymphoSign Journal 2017. [DOI: 10.14785/lymphosign-2016-0014] [Reference Citation Analysis]
192 Rigante D. A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner. Expert Review of Clinical Immunology 2017;13:571-97. [DOI: 10.1080/1744666x.2017.1280396] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
193 Hawkey CJ, Hommes DW. Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases? Gastroenterology 2017;152:389-397.e2. [PMID: 27845055 DOI: 10.1053/j.gastro.2016.11.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
194 Silverberg M, O’donnell S. Do Genes Matter? Clinical Gastroenterology 2017. [DOI: 10.1007/978-3-319-53763-4_3] [Reference Citation Analysis]
195 Uchida K, Inoue M, Koike Y, Matsushita K, Kondo S, Okita Y, Fujikawa H, Hiro J, Toiyama Y, Araki T, Kusunoki M. Forefront of Medical Care for Children with Inflammatory Bowel Disease. Journal of Japan Society of Coloproctology 2017;70:633-644. [DOI: 10.3862/jcoloproctology.70.633] [Reference Citation Analysis]
196 Lamireau T, Enaud R. Differential Diagnosis of Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_17] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
197 de Zoeten EF, Fuss IJ. Cytokines and Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_3] [Reference Citation Analysis]
198 Lee WS, Ng RT, Chan KW, Lau YL. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort. World J Gastroenterol 2016; 22(48): 10653-10662 [PMID: 28082818 DOI: 10.3748/wjg.v22.i48.10653] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
199 Ostrowski J, Paziewska A, Lazowska I, Ambrozkiewicz F, Goryca K, Kulecka M, Rawa T, Karczmarski J, Dabrowska M, Zeber-Lubecka N. Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population. Sci Rep. 2016;6:39831. [PMID: 28008999 DOI: 10.1038/srep39831] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
200 Bilsborough J, Targan SR, Snapper SB. Therapeutic Targets in Inflammatory Bowel Disease: Current and Future. Am J Gastroenterol Suppl 2016;3:27-37. [DOI: 10.1038/ajgsup.2016.18] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
201 Boyapati RK, Kalla R, Satsangi J, Ho GT. Biomarkers in Search of Precision Medicine in IBD. Am J Gastroenterol 2016;111:1682-90. [PMID: 27670602 DOI: 10.1038/ajg.2016.441] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
202 Smith PD, Elson CO. Elucidating the Role of the Interleukin-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease. Gastroenterology 2016;151:1061-2. [PMID: 27983950 DOI: 10.1053/j.gastro.2016.10.032] [Reference Citation Analysis]
203 Shouval DS, Biswas A, Kang YH, Griffith AE, Konnikova L, Mascanfroni ID, Redhu NS, Frei SM, Field M, Doty AL, Goldsmith JD, Bhan AK, Loizides A, Weiss B, Yerushalmi B, Yanagi T, Lui X, Quintana FJ, Muise AM, Klein C, Horwitz BH, Glover SC, Bousvaros A, Snapper SB. Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. Gastroenterology 2016;151:1100-4. [PMID: 27693323 DOI: 10.1053/j.gastro.2016.08.055] [Cited by in Crossref: 119] [Cited by in F6Publishing: 120] [Article Influence: 17.0] [Reference Citation Analysis]
204 Fei L, Xu K. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway. Journal of Ethnopharmacology 2016;192:236-47. [DOI: 10.1016/j.jep.2016.07.055] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
205 Suzuki T, Sasahara Y, Kikuchi A, Kakuta H, Kashiwabara T, Ishige T, Nakayama Y, Tanaka M, Hoshino A, Kanegane H. Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study. J Clin Immunol. 2017;37:67-79. [PMID: 27747465 DOI: 10.1007/s10875-016-0339-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
206 LaBarba S, Sahn B, Glocker E, Eisele B, Jongco A, Bonagura V. The Importance of Measuring IL10 Levels in Patients with Suspected IL10/IL10R Defects. J Clin Immunol 2016;36:747-9. [PMID: 27699570 DOI: 10.1007/s10875-016-0328-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
207 Kornienko EA, Krupina AN, Gabrusskaya TV, Kalinina NM. Inflammatory bowel disease with a very early onset. Alʹm klin med 2016;44:719-733. [DOI: 10.18786/2072-0505-2016-44-6-719-733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
208 Karaca NE, Aksu G, Ulusoy E, Aksoylar S, Gozmen S, Genel F, Akarcan S, Gulez N, Hirschmugl T, Kansoy S, Boztug K, Kutukculer N. Early Diagnosis and Hematopoietic Stem Cell Transplantation for IL10R Deficiency Leading to Very Early-Onset Inflammatory Bowel Disease Are Essential in Familial Cases. Case Reports Immunol 2016;2016:5459029. [PMID: 27699073 DOI: 10.1155/2016/5459029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
209 Zeissig Y, Petersen BS, Franke A, Blumberg RS, Zeissig S. Rare phenotypes in the understanding of autoimmunity. Immunol Cell Biol 2016;94:943-8. [PMID: 27562064 DOI: 10.1038/icb.2016.76] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
210 Elshaer D, Begun J. The role of barrier function, autophagy, and cytokines in maintaining intestinal homeostasis. Semin Cell Dev Biol 2017;61:51-9. [PMID: 27565684 DOI: 10.1016/j.semcdb.2016.08.018] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
211 Oh SH, Baek J, Kim KM, Lee EJ, Jung Y, Lee YJ, Jin HS, Ye BD, Yang SK, Lee JK, Seo EJ, Lim HT, Lee I, Song K. Is Whole Exome Sequencing Clinically Practical in the Management of Pediatric Crohn's Disease? Gut Liver 2015;9:767-75. [PMID: 26503572 DOI: 10.5009/gnl15176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
212 Spalinger MR, Zeitz J, Biedermann L, Rossel JB, Sulz MC, Frei P, Scharl S, Vavricka SR, Fried M, Rogler G, Scharl M; Swiss IBD Cohort Study Group. Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort. PLoS One 2016;11:e0160215. [PMID: 27467733 DOI: 10.1371/journal.pone.0160215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
213 Shouval DS, Ebens CL, Murchie R, McCann K, Rabah R, Klein C, Muise AM, Snapper SB. Large B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;63:e15-7. [PMID: 27336593 DOI: 10.1097/MPG.0000000000000532] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
214 Cho SX, Berger PJ, Nold-Petry CA, Nold MF. The immunological landscape in necrotising enterocolitis. Expert Rev Mol Med 2016;18:e12. [PMID: 27341512 DOI: 10.1017/erm.2016.13] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
215 Miyoshi J, Chang EB. The gut microbiota and inflammatory bowel diseases. Transl Res 2017;179:38-48. [PMID: 27371886 DOI: 10.1016/j.trsl.2016.06.002] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 11.7] [Reference Citation Analysis]
216 Capriati T, Cardile S, Papadatou B, Romano C, Knafelz D, Bracci F, Diamanti A. Pediatric inflammatory bowel disease: specificity of very early onset. Expert Review of Clinical Immunology 2016;12:963-72. [DOI: 10.1080/1744666x.2016.1184571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
217 Allenspach E, Torgerson TR. Autoimmunity and Primary Immunodeficiency Disorders. J Clin Immunol 2016;36 Suppl 1:57-67. [PMID: 27210535 DOI: 10.1007/s10875-016-0294-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
218 de Jesus AA, Goldbach-Mansky R. Genetically defined autoinflammatory diseases. Oral Dis 2016;22:591-604. [PMID: 26837051 DOI: 10.1111/odi.12448] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
219 Ilott NE, Bollrath J, Danne C, Schiering C, Shale M, Adelmann K, Krausgruber T, Heger A, Sims D, Powrie F. Defining the microbial transcriptional response to colitis through integrated host and microbiome profiling. ISME J 2016;10:2389-404. [PMID: 27003245 DOI: 10.1038/ismej.2016.40] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
220 Liu TC, Stappenbeck TS. Genetics and Pathogenesis of Inflammatory Bowel Disease. Annu Rev Pathol. 2016;11:127-148. [PMID: 26907531 DOI: 10.1146/annurev-pathol-012615-044152] [Cited by in Crossref: 149] [Cited by in F6Publishing: 153] [Article Influence: 21.3] [Reference Citation Analysis]
221 Yanagi T, Mizuochi T, Takaki Y, Eda K, Mitsuyama K, Ishimura M, Takada H, Shouval DS, Griffith AE, Snapper SB, Yamashita Y, Yamamoto K. Novel exonic mutation inducing aberrant splicing in the IL10RA gene and resulting in infantile-onset inflammatory bowel disease: a case report. BMC Gastroenterol. 2016;16:10. [PMID: 26822028 DOI: 10.1186/s12876-016-0424-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
222 Fodil N, Langlais D, Gros P. Primary Immunodeficiencies and Inflammatory Disease: A Growing Genetic Intersection. Trends Immunol 2016;37:126-40. [PMID: 26791050 DOI: 10.1016/j.it.2015.12.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
223 Walkovich K, Connelly JA. Primary immunodeficiency in the neonate: Early diagnosis and management. Semin Fetal Neonatal Med 2016;21:35-43. [PMID: 26776073 DOI: 10.1016/j.siny.2015.12.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
224 Farmer J, Csomos K, Bacchetta R, Walter J. Congenital Immunodeficiency Diseases. Translational Immunology 2016. [DOI: 10.1016/b978-0-12-801577-3.00002-2] [Reference Citation Analysis]
225 Uhlig HH, Schwerd T. From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:202-12. [PMID: 26512716 DOI: 10.1097/MIB.0000000000000614] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 7.1] [Reference Citation Analysis]
226 Di Costanzo M, Morelli M, Malamisura M, Puoti MG, Berni Canani R. Immunodeficiency Disorders Resulting in Malabsorption. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_37] [Reference Citation Analysis]
227 Kuşkonmaz B, Ayvaz D, Aydemir Y, Erman B, Tavil B, Özen H, Tezcan I, Çetinkaya DU. Successful outcome with second hematopoietic stem cell transplantation in a patient with IL-10R deficiency. Bone Marrow Transplant 2016;51:615-6. [PMID: 26691419 DOI: 10.1038/bmt.2015.310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
228 Zeissig S, Petersen BS, Tomczak M, Melum E, Huc-Claustre E, Dougan SK, Laerdahl JK, Stade B, Forster M, Schreiber S, Weir D, Leichtner AM, Franke A, Blumberg RS. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4. Gut 2015;64:1889-97. [PMID: 25367873 DOI: 10.1136/gutjnl-2014-308541] [Cited by in Crossref: 93] [Cited by in F6Publishing: 90] [Article Influence: 11.6] [Reference Citation Analysis]
229 Ananthakrishnan AN, Xavier RJ, Podolsky DK. Inflammatory Bowel Diseases: Pathogenesis. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch70] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
230 Hagin D, Burroughs L, Torgerson TR. Hematopoietic Stem Cell Transplant for Immune Deficiency and Immune Dysregulation Disorders. Immunology and Allergy Clinics of North America 2015;35:695-711. [DOI: 10.1016/j.iac.2015.07.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
231 Lehman HK. Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders. Curr Allergy Asthma Rep 2015;15:53. [PMID: 26233425 DOI: 10.1007/s11882-015-0553-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
232 Levast B, Li Z, Madrenas J. The role of IL-10 in microbiome-associated immune modulation and disease tolerance. Cytokine 2015;75:291-301. [DOI: 10.1016/j.cyto.2014.11.027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
233 Dubinsky M, Braun J. Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases. Gastroenterology 2015;149:1265-1274.e3. [PMID: 26284597 DOI: 10.1053/j.gastro.2015.08.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
234 Hsu P, Santner-Nanan B, Hu M, Skarratt K, Lee CH, Stormon M, Wong M, Fuller SJ, Nanan R. IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1. J Immunol. 2015;195:3665-3674. [PMID: 26363058 DOI: 10.4049/jimmunol.1402898] [Cited by in Crossref: 156] [Cited by in F6Publishing: 162] [Article Influence: 19.5] [Reference Citation Analysis]
235 Bamias G, Pizarro TT, Cominelli F. Pathway-based approaches to the treatment of inflammatory bowel disease. Transl Res 2016;167:104-15. [PMID: 26408803 DOI: 10.1016/j.trsl.2015.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
236 Ray A, Dittel BN. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology 2015;146:359-68. [PMID: 26211540 DOI: 10.1111/imm.12511] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
237 Ray A, Basu S, Gharaibeh RZ, Cook LC, Kumar R, Lefkowitz EJ, Walker CR, Morrow CD, Franklin CL, Geiger TL, Salzman NH, Fodor A, Dittel BN. Gut Microbial Dysbiosis Due to Helicobacter Drives an Increase in Marginal Zone B Cells in the Absence of IL-10 Signaling in Macrophages. J Immunol 2015;195:3071-85. [PMID: 26324769 DOI: 10.4049/jimmunol.1500153] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
238 Eames HL, Corbin AL, Udalova IA. Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease. Transl Res 2016;167:167-82. [PMID: 26207886 DOI: 10.1016/j.trsl.2015.06.018] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
239 Louis E. When it is not inflammatory bowel disease: differential diagnosis. Curr Opin Gastroenterol 2015;31:283-9. [PMID: 26039719 DOI: 10.1097/MOG.0000000000000183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
240 Golan MA, Liu W, Shi Y, Chen L, Wang J, Liu T, Li YC. Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency. Dig Dis Sci 2015;60:1941-7. [PMID: 25894930 DOI: 10.1007/s10620-015-3634-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
241 Sziksz E, Pap D, Lippai R, Béres NJ, Fekete A, Szabó AJ, Vannay Á. Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family. Mediators Inflamm 2015;2015:764641. [PMID: 26199463 DOI: 10.1155/2015/764641] [Cited by in Crossref: 154] [Cited by in F6Publishing: 167] [Article Influence: 19.3] [Reference Citation Analysis]
242 Cutler DJ, Zwick ME, Okou DT, Prahalad S, Walters T, Guthery SL, Dubinsky M, Baldassano R, Crandall WV, Rosh J, Markowitz J, Stephens M, Kellermayer R, Pfefferkorn M, Heyman MB, LeLeiko N, Mack D, Moulton D, Kappelman MD, Kumar A, Prince J, Bose P, Mondal K, Ramachandran D, Bohnsack JF, Griffiths AM, Haberman Y, Essers J, Thompson SD, Aronow B, Keljo DJ, Hyams JS, Denson LA, Kugathasan S; PRO-KIIDS Research Group. Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping. PLoS One 2015;10:e0128074. [PMID: 26098103 DOI: 10.1371/journal.pone.0128074] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
243 Jiang W, Li X. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Mol Diagn Ther 2015;19:141-58. [DOI: 10.1007/s40291-015-0142-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
244 Carneiro-Sampaio M, Coutinho A. Early-onset autoimmune disease as a manifestation of primary immunodeficiency. Front Immunol 2015;6:185. [PMID: 25999944 DOI: 10.3389/fimmu.2015.00185] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
245 Tangye SG. Advances in IL-21 biology - enhancing our understanding of human disease. Curr Opin Immunol 2015;34:107-15. [PMID: 25801685 DOI: 10.1016/j.coi.2015.02.010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
246 Gassas A, Courtney S, Armstrong C, Kapllani E, Muise AM, Schechter T. Unrelated donor hematopoietic stem cell transplantation for infantile enteropathy due to IL-10/IL-10 receptor defect. Pediatr Transplant 2015;19:E101-3. [PMID: 25761563 DOI: 10.1111/petr.12452] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
247 Beser OF, Conde CD, Serwas NK, Cokugras FC, Kutlu T, Boztug K, Erkan T. Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2015;60:332-8. [PMID: 25373860 DOI: 10.1097/MPG.0000000000000621] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
248 de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 2015;33:823-74. [PMID: 25706096 DOI: 10.1146/annurev-immunol-032414-112227] [Cited by in Crossref: 187] [Cited by in F6Publishing: 189] [Article Influence: 23.4] [Reference Citation Analysis]
249 Holgersen K, Dobie R, Farquharson C, vanʼt Hof R, Ahmed SF, Hansen AK, Holm TL. Piroxicam treatment augments bone abnormalities in interleukin-10 knockout mice. Inflamm Bowel Dis 2015;21:257-66. [PMID: 25569742 DOI: 10.1097/MIB.0000000000000269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
250 Guénard F, Lamontagne M, Bossé Y, Deshaies Y, Cianflone K, Kral JG, Marceau P, Vohl MC. Influences of gestational obesity on associations between genotypes and gene expression levels in offspring following maternal gastrointestinal bypass surgery for obesity. PLoS One 2015;10:e0117011. [PMID: 25603303 DOI: 10.1371/journal.pone.0117011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
251 Boirivant M. Experimental Models of Gastrointestinal Inflammatory Diseases. Mucosal Immunology 2015. [DOI: 10.1016/b978-0-12-415847-4.00079-3] [Reference Citation Analysis]
252 Goldbach-mansky R, de Jesus AA, Mcdermott MF, Kastner DL. Monogenic autoinflammatory diseases. Rheumatology 2015. [DOI: 10.1016/b978-0-323-09138-1.00165-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
253 Zeissig Y, Petersen BS, Milutinovic S, Bosse E, Mayr G, Peuker K, Hartwig J, Keller A, Kohl M, Laass MW, Billmann-Born S, Brandau H, Feller AC, Röcken C, Schrappe M, Rosenstiel P, Reed JC, Schreiber S, Franke A, Zeissig S. XIAP variants in male Crohn's disease. Gut 2015;64:66-76. [PMID: 24572142 DOI: 10.1136/gutjnl-2013-306520] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 13.8] [Reference Citation Analysis]
254 Strober W, Fuss IJ. Protein-Losing Enteropathies. Mucosal Immunology. Elsevier; 2015. pp. 1667-94. [DOI: 10.1016/b978-0-12-415847-4.00086-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
255 Vaiopoulou A, Gazouli M, Papadopoulou A, Anagnostopoulos AK, Karamanolis G, Theodoropoulos GE, M'Koma A, Tsangaris GT. Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr 2015;60:42-7. [PMID: 25250685 DOI: 10.1097/MPG.0000000000000579] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
256 Kim VH, Brager R, Upton J, Ngan B, Newell A, Roifman M, Muise AM, Benseler SM, Grunebaum E, Roifman CM. Hematopoietic stem cell transplantation completely reversed colitis but not arthritis in IL-10Rα deficiency. LymphoSign Journal 2014;1:77-86. [DOI: 10.14785/lpsn-2014-0018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
257 Ma CS, Uzel G, Tangye SG. Human T follicular helper cells in primary immunodeficiencies. Current Opinion in Pediatrics 2014;26:720-6. [DOI: 10.1097/mop.0000000000000157] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
258 Tran T, Amiji MM. Targeted delivery systems for biological therapies of inflammatory diseases. Expert Opinion on Drug Delivery 2014;12:393-414. [DOI: 10.1517/17425247.2015.972931] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
259 Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, Ouahed J, Wilson DC, Travis SP, Turner D, Klein C, Snapper SB, Muise AM; COLORS in IBD Study Group and NEOPICS. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology 2014;147:990-1007.e3. [PMID: 25058236 DOI: 10.1053/j.gastro.2014.07.023] [Cited by in Crossref: 413] [Cited by in F6Publishing: 456] [Article Influence: 45.9] [Reference Citation Analysis]
260 Lee CH, Hsu P, Nanan B, Nanan R, Wong M, Gaskin KJ, Leong RW, Murchie R, Muise AM, Stormon MO. Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease. J Crohns Colitis 2014;8:1551-6. [PMID: 24813381 DOI: 10.1016/j.crohns.2014.04.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
261 McCann MJ, Johnston S, Reilly K, Men X, Burgess EJ, Perry NB, Roy NC. The effect of turmeric (Curcuma longa) extract on the functionality of the solute carrier protein 22 A4 (SLC22A4) and interleukin-10 (IL-10) variants associated with inflammatory bowel disease. Nutrients 2014;6:4178-90. [PMID: 25314644 DOI: 10.3390/nu6104178] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
262 Benchimol EI, Mack DR, Nguyen GC, Snapper SB, Li W, Mojaverian N, Quach P, Muise AM. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology 2014;147:803-813.e7; quiz e14-5. [PMID: 24951840 DOI: 10.1053/j.gastro.2014.06.023] [Cited by in Crossref: 172] [Cited by in F6Publishing: 174] [Article Influence: 19.1] [Reference Citation Analysis]
263 Coelho T, Andreoletti G, Ashton JJ, Pengelly RJ, Gao Y, RamaKrishnan A, Batra A, Beattie RM, Williams AP, Ennis S. Immuno-genomic profiling of patients with inflammatory bowel disease: a systematic review of genetic and functional in vivo studies of implicated genes. Inflamm Bowel Dis 2014;20:1813-9. [PMID: 25171511 DOI: 10.1097/MIB.0000000000000174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
264 Okou DT, Kugathasan S. Role of genetics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2014;20:1878-84. [PMID: 25118609 DOI: 10.1097/MIB.0000000000000085] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
265 Im E, Jung J, Pothoulakis C, Rhee SH. Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10(-/-) mice. Gastroenterology 2014;147:667-679.e10. [PMID: 24882466 DOI: 10.1053/j.gastro.2014.05.034] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
266 Billiet T, Vermeire S. Differences between adults and children: genetics and beyond. Expert Rev Gastroenterol Hepatol. 2015;9:191-196. [PMID: 25134842 DOI: 10.1586/17474124.2014.950228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
267 Rigoli L, Caruso RA. Inflammatory bowel disease in pediatric and adolescent patients: A biomolecular and histopathological review. World J Gastroenterol 2014; 20(30): 10262-10278 [PMID: 25132743 DOI: 10.3748/wjg.v20.i30.10262] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
268 Gjymishka A, Coman RM, Brusko TM, Glover SC. Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes. Immunotherapy. 2013;5:1357-1366. [PMID: 24283846 DOI: 10.2217/imt.13.130] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
269 Vossenkämper A, Hundsrucker C, Page K, van Maurik A, Sanders TJ, Stagg AJ, Das L, MacDonald TT. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease. Gastroenterology 2014;147:172-83. [PMID: 24704524 DOI: 10.1053/j.gastro.2014.03.049] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
270 Ko JS. [Is infantile inflammatory bowel disease curable with hematopoietic stem cell transplantation?]. Korean J Gastroenterol 2013;62:313-4. [PMID: 24404649 DOI: 10.4166/kjg.2013.62.5.313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
271 Hyams JS. Standardized recording of parameters related to the natural history of inflammatory bowel disease: from Montreal to Paris. Dig Dis 2014;32:337-44. [PMID: 24969277 DOI: 10.1159/000358133] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
272 Raine T. Insights from immunology: new targets for new drugs? Best Pract Res Clin Gastroenterol 2014;28:411-20. [PMID: 24913381 DOI: 10.1016/j.bpg.2014.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
273 Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho KL, Veres G, Russell RK, Paerregaard A, Buderus S, Greer ML, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC; European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014;58:795-806. [PMID: 24231644 DOI: 10.1097/MPG.0000000000000239] [Cited by in Crossref: 735] [Cited by in F6Publishing: 623] [Article Influence: 81.7] [Reference Citation Analysis]
274 Van Limbergen J, Radford-Smith G, Satsangi J. Advances in IBD genetics. Nat Rev Gastroenterol Hepatol 2014;11:372-85. [PMID: 24614343 DOI: 10.1038/nrgastro.2014.27] [Cited by in Crossref: 99] [Cited by in F6Publishing: 82] [Article Influence: 11.0] [Reference Citation Analysis]
275 Russo RA, Brogan PA. Monogenic autoinflammatory diseases. Rheumatology (Oxford) 2014;53:1927-39. [PMID: 24831056 DOI: 10.1093/rheumatology/keu170] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
276 Varzaneh FN, Keller B, Unger S, Aghamohammadi A, Warnatz K, Rezaei N. Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge. J Clin Immunol 2014;34:524-43. [PMID: 24827633 DOI: 10.1007/s10875-014-0053-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
277 Shouval DS, Ouahed J, Biswas A, Goettel JA, Horwitz BH, Klein C, Muise AM, Snapper SB. Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. Adv Immunol 2014;122:177-210. [PMID: 24507158 DOI: 10.1016/B978-0-12-800267-4.00005-5] [Cited by in Crossref: 189] [Cited by in F6Publishing: 106] [Article Influence: 21.0] [Reference Citation Analysis]
278 Eksteen B. Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis. Br Med Bull. 2014;110:89-98. [PMID: 24795363 DOI: 10.1093/bmb/ldu008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
279 Shim JO, Seo JK. Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations. J Hum Genet. 2014;59:337-341. [PMID: 24785691 DOI: 10.1038/jhg.2014.32] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
280 Shouval DS, Biswas A, Goettel JA, McCann K, Conaway E, Redhu NS, Mascanfroni ID, Al Adham Z, Lavoie S, Ibourk M. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity. 2014;40:706-719. [PMID: 24792912 DOI: 10.1016/j.immuni.2014.03.011] [Cited by in Crossref: 356] [Cited by in F6Publishing: 367] [Article Influence: 39.6] [Reference Citation Analysis]
281 Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329-342. [PMID: 24751956 DOI: 10.1038/nri3661] [Cited by in Crossref: 1424] [Cited by in F6Publishing: 1481] [Article Influence: 158.2] [Reference Citation Analysis]
282 Salzer E, Kansu A, Sic H, Májek P, Ikincioğullari A, Dogu FE, Prengemann NK, Santos-Valente E, Pickl WF, Bilic I, Ban SA, Kuloğlu Z, Demir AM, Ensari A, Colinge J, Rizzi M, Eibel H, Boztug K. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. J Allergy Clin Immunol 2014;133:1651-9.e12. [PMID: 24746753 DOI: 10.1016/j.jaci.2014.02.034] [Cited by in Crossref: 98] [Cited by in F6Publishing: 75] [Article Influence: 10.9] [Reference Citation Analysis]
283 Kobold S, Völk S, Clauditz T, Küpper NJ, Minner S, Tufman A, Düwell P, Lindner M, Koch I, Heidegger S. Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells. J Thorac Oncol. 2013;8:1032-1042. [PMID: 23774470 DOI: 10.1097/JTO.0b013e31829923c8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
284 Avitzur Y, Guo C, Mastropaolo LA, Bahrami E, Chen H, Zhao Z, Elkadri A, Dhillon S, Murchie R, Fattouh R, Huynh H, Walker JL, Wales PW, Cutz E, Kakuta Y, Dudley J, Kammermeier J, Powrie F, Shah N, Walz C, Nathrath M, Kotlarz D, Puchaka J, Krieger JR, Racek T, Kirchner T, Walters TD, Brumell JH, Griffiths AM, Rezaei N, Rashtian P, Najafi M, Monajemzadeh M, Pelsue S, McGovern DP, Uhlig HH, Schadt E, Klein C, Snapper SB, Muise AM. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology 2014;146:1028-39. [PMID: 24417819 DOI: 10.1053/j.gastro.2014.01.015] [Cited by in Crossref: 148] [Cited by in F6Publishing: 151] [Article Influence: 16.4] [Reference Citation Analysis]
285 Hsu P, Nanan RK. Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol 2014;5:125. [PMID: 24734032 DOI: 10.3389/fimmu.2014.00125] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 8.4] [Reference Citation Analysis]
286 Heine G, Drozdenko G, Grün JR, Chang H, Radbruch A, Worm M. Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts: Cellular immune response. Eur J Immunol 2014;44:1615-21. [DOI: 10.1002/eji.201343822] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 7.2] [Reference Citation Analysis]
287 Moens L, Tangye SG. Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage. Front Immunol 2014;5:65. [PMID: 24600453 DOI: 10.3389/fimmu.2014.00065] [Cited by in Crossref: 127] [Cited by in F6Publishing: 135] [Article Influence: 14.1] [Reference Citation Analysis]
288 Marvel DM, Finn OJ. Global Inhibition of DC Priming Capacity in the Spleen of Self-Antigen Vaccinated Mice Requires IL-10. Front Immunol 2014;5:59. [PMID: 24596571 DOI: 10.3389/fimmu.2014.00059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
289 Murugan D, Albert MH, Langemeier J, Bohne J, Puchalka J, Järvinen PM, Hauck F, Klenk AK, Prell C, Schatz S, Diestelhorst J, Sciskala B, Kohistani N, Belohradsky BH, Müller S, Kirchner T, Walter MR, Bufler P, Muise AM, Snapper SB, Koletzko S, Klein C, Kotlarz D. Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol 2014;34:331-9. [PMID: 24519095 DOI: 10.1007/s10875-014-9992-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
290 Bates J, Diehl L. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? J Pathol. 2014;232:112-120. [PMID: 24122796 DOI: 10.1002/path.4277] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
291 Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol 2014;11:88-98. [PMID: 24345891 DOI: 10.1038/nrgastro.2013.240] [Cited by in Crossref: 139] [Cited by in F6Publishing: 109] [Article Influence: 15.4] [Reference Citation Analysis]
292 Engelhardt KR, Grimbacher B. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr Top Microbiol Immunol 2014;380:1-18. [PMID: 25004811 DOI: 10.1007/978-3-662-43492-5_1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 70] [Article Influence: 3.9] [Reference Citation Analysis]
293 Glocker E, Speckmann C. Autoinflammatory Diseases Predominantly Affecting the Gastrointestinal Tract. Stiehm's Immune Deficiencies 2014. [DOI: 10.1016/b978-0-12-405546-9.00026-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
294 Gasparetto M, Guariso G. Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age. Gastroenterol Res Pract. 2013;2013:829040. [PMID: 24454343 DOI: 10.1155/2013/829040] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
295 Galatola M, Miele E, Strisciuglio C, Paparo L, Rega D, Delrio P, Duraturo F, Martinelli M, Rossi GB, Staiano A, Izzo P, Rosa MD. Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis. World J Gastroenterol 2013; 19(46): 8659-8670 [PMID: 24379584 DOI: 10.3748/wjg.v19.i46.8659] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
296 Uhlig HH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut 2013;62:1795-805. [PMID: 24203055 DOI: 10.1136/gutjnl-2012-303956] [Cited by in Crossref: 240] [Cited by in F6Publishing: 207] [Article Influence: 24.0] [Reference Citation Analysis]
297 Aloi M, D'Arcangelo G, Pofi F, Vassallo F, Rizzo V, Nuti F, Di Nardo G, Pierdomenico M, Viola F, Cucchiara S. Presenting features and disease course of pediatric ulcerative colitis. J Crohns Colitis 2013;7:e509-15. [PMID: 23583691 DOI: 10.1016/j.crohns.2013.03.007] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
298 Pigneur B, Escher J, Elawad M, Lima R, Buderus S, Kierkus J, Guariso G, Canioni D, Lambot K, Talbotec C, Shah N, Begue B, Rieux-Laucat F, Goulet O, Cerf-Bensussan N, Neven B, Ruemmele FM. Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group. Inflamm Bowel Dis 2013;19:2820-8. [PMID: 24216686 DOI: 10.1097/01.MIB.0000435439.22484.d3] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
299 Lin Y, Wang SL, Yue YY, Zheng CQ. Mechanisms underlying therapeutic effects of recombinant human granulocyte colony-stimulating factor against TNBS-induced experimental colitis in mice. Shijie Huaren Xiaohua Zazhi 2013; 21(33): 3700-3705 [DOI: 10.11569/wcjd.v21.i33.3700] [Reference Citation Analysis]
300 Deenick EK, Avery DT, Chan A, Berglund LJ, Ives ML, Moens L, Stoddard JL, Bustamante J, Boisson-Dupuis S, Tsumura M, Kobayashi M, Arkwright PD, Averbuch D, Engelhard D, Roesler J, Peake J, Wong M, Adelstein S, Choo S, Smart JM, French MA, Fulcher DA, Cook MC, Picard C, Durandy A, Klein C, Holland SM, Uzel G, Casanova JL, Ma CS, Tangye SG. Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. J Exp Med 2013;210:2739-53. [PMID: 24218138 DOI: 10.1084/jem.20130323] [Cited by in Crossref: 124] [Cited by in F6Publishing: 129] [Article Influence: 12.4] [Reference Citation Analysis]
301 Gibson DJ, Ryan EJ, Doherty GA. Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2716-24. [PMID: 23899545 DOI: 10.1097/MIB.0b013e31829ed7df] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
302 Helbling R, Nyddeger A, Angelini F, Von Scheven Gete A, Hofer M. P03-024 – Early onset IBD treated by tocilizumab. Pediatr Rheumatol 2013;11:A222. [DOI: 10.1186/1546-0096-11-s1-a222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
303 Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, Jobin C. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep. 2013;3:2868. [PMID: 24100376 DOI: 10.1038/srep02868] [Cited by in Crossref: 80] [Cited by in F6Publishing: 84] [Article Influence: 8.0] [Reference Citation Analysis]
304 Neven B, Mamessier E, Bruneau J, Kaltenbach S, Kotlarz D, Suarez F, Masliah-Planchon J, Billot K, Canioni D, Frange P. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood. 2013;122:3713-3722. [PMID: 24089328 DOI: 10.1182/blood-2013-06-508267] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 9.5] [Reference Citation Analysis]
305 Verdier J, Ruemmele FM. Molecular mechanisms and cell targets of Th17 cells in the gastrointestinal tract: an innate sense of adaptivity. Int Rev Immunol 2013;32:475-92. [PMID: 24069950 DOI: 10.3109/08830185.2013.829471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
306 Sanchez GA, de Jesus AA, Goldbach-Mansky R. Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation. Rheum Dis Clin North Am 2013;39:701-34. [PMID: 24182851 DOI: 10.1016/j.rdc.2013.08.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
307 Buettner M, Bleich A. Mapping colitis susceptibility in mouse models: distal chromosome 3 contains major loci related to Cdcs1. Physiol Genomics 2013;45:925-30. [PMID: 24022218 DOI: 10.1152/physiolgenomics.00084.2013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
308 Biancheri P, Powell N, Monteleone G, Lord G, MacDonald TT. The challenges of stratifying patients for trials in inflammatory bowel disease. Trends Immunol 2013;34:564-71. [PMID: 24035478 DOI: 10.1016/j.it.2013.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
309 Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol 2013;11:1050-63. [PMID: 23501398 DOI: 10.1016/j.cgh.2013.02.024] [Cited by in Crossref: 137] [Cited by in F6Publishing: 162] [Article Influence: 13.7] [Reference Citation Analysis]
310 Dinwiddie DL, Bracken JM, Bass JA, Christenson K, Soden SE, Saunders CJ, Miller NA, Singh V, Zwick DL, Roberts CC, Dalal J, Kingsmore SF. Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing. Genomics 2013;102:442-7. [PMID: 24001973 DOI: 10.1016/j.ygeno.2013.08.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
311 Wang MH, Fiocchi C, Ripke S, Zhu X, Duerr RH, Achkar JP. A novel approach to detect cumulative genetic effects and genetic interactions in Crohn's disease. Inflamm Bowel Dis 2013;19:1799-808. [PMID: 23598818 DOI: 10.1097/MIB.0b013e31828706a0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
312 Gouilleux-gruart V, Schleinitz N, Fischer A. Primary immune deficiencies: practical questions. Current Opinion in Allergy & Clinical Immunology 2013;13:S67-78. [DOI: 10.1097/01.all.0000433133.93564.c7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
313 Harrison OJ, Powrie FM. Regulatory T cells and immune tolerance in the intestine. Cold Spring Harb Perspect Biol 2013;5:a018341. [PMID: 23818502 DOI: 10.1101/cshperspect.a018341] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 7.8] [Reference Citation Analysis]
314 Monteleone G, Caruso R, Pallone F. Targets for new immunomodulation strategies in inflammatory bowel disease. Autoimmun Rev. 2014;13:11-14. [PMID: 23774108 DOI: 10.1016/j.autrev.2013.06.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
315 Elinav E, Peer D. Harnessing nanomedicine for mucosal theranostics--a silver bullet at last? ACS Nano 2013;7:2883-90. [PMID: 23570555 DOI: 10.1021/nn400885b] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
316 Almeida de Jesus A, Goldbach-Mansky R. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol. 2013;147:155-174. [PMID: 23711932 DOI: 10.1016/j.clim.2013.03.016] [Cited by in Crossref: 138] [Cited by in F6Publishing: 145] [Article Influence: 13.8] [Reference Citation Analysis]
317 Shah N, Kammermeier J, Elawad M, Glocker EO. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease. Curr Allergy Asthma Rep. 2012;12:373-379. [PMID: 22890722 DOI: 10.1007/s11882-012-0286-z] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 7.6] [Reference Citation Analysis]
318 Mizoguchi A, Andoh A. Animal Models of Inflammatory Bowel Disease for Drug Discovery. Animal Models for the Study of Human Disease 2013. [DOI: 10.1016/b978-0-12-415894-8.00022-1] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
319 Dalal J. Mesenchymal Stromal Cell (MSC) Therapy for Crohn’s Disease. Essentials of Mesenchymal Stem Cell Biology and Its Clinical Translation 2013. [DOI: 10.1007/978-94-007-6716-4_15] [Reference Citation Analysis]
320 Zhu XC, Macdermott RP. A Primer on IBD: Phenotypes, Diagnosis, Treatment, and Clinical Challenges. Molecular Genetics of Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-8256-7_1] [Reference Citation Analysis]
321 Mizoguchi E, Mizoguchi A, Bhan AK. Insights from Recent Advances in Animal Models of Inflammatory Bowel Disease. Molecular Genetics of Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-8256-7_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
322 Engelhardt KR, Shah N, Faizura-Yeop I, Kocacik Uygun DF, Frede N, Muise AM, Shteyer E, Filiz S, Chee R, Elawad M. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;131:825-830. [PMID: 23158016 DOI: 10.1016/j.jaci.2012.09.025] [Cited by in Crossref: 196] [Cited by in F6Publishing: 160] [Article Influence: 17.8] [Reference Citation Analysis]
323 Hisamatsu T, Kanai T, Mikami Y, Yoneno K, Matsuoka K, Hibi T. Immune aspects of the pathogenesis of inflammatory bowel disease. Pharmacol Ther. 2013;137:283-297. [PMID: 23103332 DOI: 10.1016/j.pharmthera.2012.10.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 69] [Article Influence: 5.5] [Reference Citation Analysis]
324 Beier R, Schulz A, Hönig M, Eyrich M, Schlegel PG, Holter W, Stachel KD, Ehlert K, Greil J, Nürnberger W, Wössmann W, Bader P, Urban C, Müller I, Suttorp M, Sauer M, Gruhn B, Meisel R, Zimmermann M, Sykora KW. Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience. Bone Marrow Transplant 2013;48:491-501. [PMID: 23085832 DOI: 10.1038/bmt.2012.188] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
325 Muise AM, Snapper SB, Kugathasan S. The age of gene discovery in very early onset inflammatory bowel disease. Gastroenterology 2012;143:285-8. [PMID: 22727850 DOI: 10.1053/j.gastro.2012.06.025] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
326 [DOI: 10.1101/098574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]